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ABSTRACT
Transcatheter aortic valve replacement (TAVR) is an established therapy alternative
to surgical valve replacement in high-risk and intermediate-risk patients with severe aortic
stenosis. Currently, although TAVR is an alternative and less-invasive treatment for highrisk and intermediate-risk patients, surgical aortic valves replacement (SAVR) was still
considered as the gold standard for low-risk patients. TAVR could potentially be applied
to lower-risk younger patients if the indications can be safely expanded to the patients and
transcatheter aortic valve (TAV) long-term durability can match with that of surgical
bioprostheses. In contrast to surgical aortic valves (SAVs), there have been limited clinical
data on the long-term durability of TAV devices. In the absence of enough long-term valve
durability data, accurate structural simulations and computational modeling become an
integral part of the evaluation. Thus, the objectives of this dissertation were to employ invitro experiments and inverse finite element (FE) analyses to obtain accurate material
properties of soft tissue employed in commercial available TAVs and then to implement
them in computational simulations to determine leaflet stress and strain distributions for
proper assessment of the TAVs long-term durability. Therefore, the main goal of this study
was to develop an automated computational framework to minimize the peak stress on the
leaflets under and optimize the TAV leaflet shape under physiological loading conditions.
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In addition, the impact of incomplete TAV expansion and thickness reduction on leaflet
stress and strain distribution was assessed in this dissertation.
The results of this study showed that 2-3mm incomplete TAV stent expansion induced
localized high stress regions within the TAV commissures, while 4-5mm incomplete stent
expansion induced localized high stress regions within the belly of the TAV leaflets during
the diastolic phase of the cardiac cycle. This study also presented three-dimensional
anisotropic mechanical properties of leaflets used in Carpentier-Edwards PERIMOUNT
Magna, Edwards SAPIEN 3 and Medtronic CoreValve. The optimized material parameters
for each valve were implemented in FE simulations to assess the leaflet deformation and
stress distribution. The results showed the CoreValve had the lowest peak stress value at
the identical pressure value during diastole compared to the CE PERIMOUNT Magna and
Edwards SAPIEN 3. Eventually, within the chosen design parameters in the optimization
framework, we have achieved new designs for TAVs leaflet geometry in which the peak
stress was 8.2% and 30.3% less than the corresponding surgical valves for 23 and 26 mm
diameters, respectively. In addition, the leaflet peak stress of best TAV design obtained
from the optimization framework showed the leaflet peak stress was 74.8% lower than the
Edwards SAPIEN 3 TAV. The developed optimization framework may provide a more
reliable TAV design with longer valve durability in comparison currently available
designs. The present work presents a reliable approach to determine mechanical properties
of pericardial valves and compare leaflet stress and strain distribution among different
bioprostheses under physiological loading conditions.
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CHAPTER 1: INTRODUCTION
1.1 Anatomy and Physiology of the Heart
The heart pumps oxygenated blood through the body as the main part of the circulatory
system is the human body. The heart is composed of two sides, right and left side. Each
side is divided into two chambers. The atrium is the upper chamber which receives blood
as it enters. The ventricle is the lower chamber with a thicker muscular wall than the atrium
from which blood is pumped out. The heart has four chambers and four valves shown in
Fig. 1.1. Chambers pump out oxygenated blood to the rest of the body and receive deoxygenated blood from the body. The valves make sure that blood flow is always
unidirectional in the right direction through the heart. One cardiac cycle can be divided into
two parts - diastole and systole. At diastole, the left atrium receives oxygenated blood via
pulmonary veins when the heart muscles are relaxed. During systole, the heart muscle
contracts and left ventricle pressure significantly increases which pump the blood out of
the heart. A typical pressure waveform through a cardiac cycle was shown in Fig. 1.2. At
the beginning of systole, aortic pressure is about 80 mmHg whereas it is 120 mmHg near
diastole. Transvalvular pressure gradient which is the net pressure difference between the
ascending aorta and the left ventricle is large enough to make aortic valve leaflets open
during systole.
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Figure 1.1: Anatomical structure of the human heart. RA: right atrium, RV: right ventricle,
LA: left atrium, LV: left ventricle, T: tricuspid valve, P: pulmonary valve, M: mitral valve,
A: aortic valve, PA: pulmonary artery, AO: aorta. Arrows indicate the path of blood flow,
adapted from (Thubrikar 2018).

Figure 1.2: A Wiggers diagram and blood pressure waveforms during diastole and systole,
adapted from (Sarazan 2014).
2

1.2 Heart Valve Diseases
The conditions that affect your heart including blood vessel diseases and congenital
heart defects are called heart disease. Other conditions such as heart valve problems,
irregular heartbeat and abnormal heart rhythms also are considered forms of heart disease.
Among heart diseases, valvular diseases are the most significant cause of cardiac death
among people in the world. When the heart valves do not function properly in opening all
the way and closing tightly, it's called valvular heart diseases. There are number of causes
of valvular heart diseases including congenital heart defect, infections, rheumatic fever and
calcification in valves. Heart valves can be affected by two ways, stenosis and
regurgitation. Stenosis is the term for narrowing of the valve that fails to open fully. A
condition in which blood flows back through the valve in an inappropriate way is called
regurgitation. In aortic valve regurgitation, leaflets do not seal properly during diastole
which causes a failure of the one-way valve. In 2013, heart valve disease caused more than
50,000 deaths in the United States based on the American Heart Association report
(Mozaffarian et al. 2015). According to the report, 67.5% of valvular heart diseases were
because of aortic valve disorders.
1.3 Aortic Valve Stenosis
Aortic valve stenosis is one of the most prevalent type of cardiovascular disease among
aortic valve disorders (Roberts and Ko 2005) . Either degenerative calcification in trileaflet
aortic valves or a congenital heart defect called a bicuspid aortic valve can lead to aortic
stenosis. In general, aortic stenosis is a problem for the aortic valve that prevents the valve
to open fully due to calcified or defected leaflets. Especially in a narrowed aortic valve,
3

blood flow out from the heart is slow and that make the heart work very hard to pump
blood through it. Aortic stenosis is categorized as mild, moderate, severe (Vahanian and
Otto 2010). Symptoms of heart disease may not be present in most patients with mild to
moderate aortic stenosis. However, people with severe aortic stenosis usually have classic
symptoms such as angina, syncope, or dyspnea (Vahanian and Otto 2010). Based on the
severity of aortic stenosis and patient’s conditions, the most appropriate treatment is
determined by a team of cardiologists and surgeons. Surgical options for aortic stenosis
include aortic valve replacement (AVR), aortic valve repair and percutaneous aortic
balloon valvuloplasty. However, AVR is the only definitive treatment which has relatively
low mortality rate compared to other methods for patients with severe aortic stenosis
(Aranki et al. 1993). Surgical aortic valve replacement (SAVR) via open-heart surgery,
either with a mechanical or bioprosthetic heart valve, is a gold standard therapy for patients
who have severe aortic stenosis (Walther et al. 2012). In addition, transcatheter aortic valve
replacement (TAVR) is an established treatment alternative to SAVR in inoperable and
high-risk patients (Cribier et al. 2002).
1.4 Surgical Aortic Valve Replacement
SAVR has been assumed the primary surgical therapy of patients who suffer from
severe aortic stenosis. During this procedure, surgeons remove the degenerated aortic valve
and replace it with one of two types of artificial aortic valves: mechanical valves and tissue
valves (see Fig. 1.3). Because of some problems associated with mechanical valves such
as thrombosis, bioprosthetic heart valve (BHV) replacements are recommended for
patients who cannot take blood thinners or are below 60 years old, due to durability
4

concerns of bioprosthetic valves. Bioprosthetic valves are built with bovine or porcine
pericardial tissues, which can be taken from animal tissue and be sewed to a metal frame,
chemically treated with glutaraldehyde. It can imitate the one-way blood flow of the heart
valve leaflets by sealing against each other. Stented and stentless common bioprosthetic
surgical valves are shown in Fig. 1.4. Surgical bioprosthetic aortic valves (SAVs) have
been reputed for their outstanding biocompatibility and hemodynamic performance
(Laflamme et al. 2015). However, they have limited durability compared to mechanical
valves.

Among

commercially

available

BHVs,

the

Carpentier-Edwards

(CE)

PERIMOUNT pericardial bioprosthesis (Edwards Lifesciences, Irvine, CA), shown in Fig.
1.4, has demonstrated a low rate of structural valve deterioration at 20 years which makes
it as a reliable choice for SAVR (Jamieson et al. 2005). Despite the CE PERIMOUNT
valve’s long-term durability, SAVs may not be a suitable treatment method for patients
who have severe aortic stenosis and considered high-risk to have open heart surgery.

Figure 1.3: (A) A mechanical valve (courtesy of www.heart-valve-surgery.com) (B) A
tissue heart valve (courtesy of www.edwards.com).
5

Figure 1.4: (A) Stented pericardial bovine bioprosthetic valves. (B) Stented porcine aortic
valve bioprostheses. (C) Stentless bioprosthetic valves. CE = Carpentier-Edwards; SPV =
stentless porcine valve, adapted from (Piazza et al. 2011).
1.5 Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) is an established therapy alternative
to surgical valve replacement in high-risk and intermediate-risk patients with severe aortic
stenosis (Leon et al. 2010). Considering the severity of aortic stenosis severity and the
arterial system in patients, the TAVR procedure is performed using one of four different
access approaches: transfemoral, transapical, transaortic and transcarotid (Thourani et al.
2015). During the transfemoral approach, transcatheter aortic valves (TAVs) are delivered
via a catheter through the femoral artery using a tiny incision in the patient’s leg. In the
transapical approach, using a small incision in the chest, TAVs are delivered via a catheter
through a large artery or through the tip of the bottom left chamber of the heart (left
6

ventricle) which is known as the apex. Alternatively, TAVs can be delivered through the
ascending aorta via a catheter in the transaortic approach. For patients who have vascular
anatomy issues that prevent transfemoral access, transcarotid arterial access may be an
alternative. Although TAV manufacturers use a similar biologic leaflets as surgical
bioprostheses and therefore it would be expected to degenerate via similar mechanisms,
TAV design and implantation configuration are substantially different than surgical
bioprostheses (Rodes-Cabau 2012, Bourantas and Serruys 2014).
In terms of recovery time, TAVR requires a shorter hospital stay (average 3-5 days)
(Webb, Carere, and Lichtenstein 2007) compared to SAVR which is about three months.
Several modern TAV designs were shown in Fig. 1.5. The use of this treatment has become
increasingly common worldwide since 2002. When Cribier (Cribier et al. 2002) performed
the procedure the procedure for the first time, to date, more than 350,000 patients have
undergone TAVR across the globe (Barbanti et al. 2017). Currently, although TAVR is an
alternative and less-invasive treatment for high-risk and intermediate-risk patients (Kodali
et al. 2012), SAVR is still considered as the gold standard for low-risk patients. TAVR
could potentially be applied to lower-risk younger patients if the indications can be safely
expanded to the patients and TAV long-term durability can match with that of surgical
bioprostheses. In contrary to SAVs, there have been limited clinical data on the long-term
durability of TAV devices.
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Figure 1.5: Several designs for transcatheter aortic valves, adapted from (Kheradvar et al.
2015).
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1.6 Long-term Durability of Tissue Heart Valves
In the past few decades, the use of bioprosthetic valves for aortic valve replacement
has increased considerably. To choose an appropriate bioprosthetic heart valve for aortic
valve replacement, long-term durability of tissue heart valves is an important factor.
Although more than 350,000 patients have undergone TAVR worldwide since 2002, to
date, there have been limited publications on the long-term durability of TAVR. To expand
TAV technology to lower risk younger patients for whom surgical results are excellent,
TAV durability must match that of surgical bioprostheses. Therefore, proper evaluation of
TAV longevity and tissue degeneration mechanism are crucial for potential expansion of
TAVR to lower-risk patients.
Recently, the first long-term durability assessment of TAVs was conducted by Dvir
and colleagues (Dvir et al. 2016). In their study, 378 patients who underwent TAVR
including Cribier-Edwards, Edwards SAPIEN, and Edwards SAPIEN XT TAVs were
followed up to 10 years. Based on their results, the estimated structural valve degeneration
rate was approximately 50% at 8 years. In the absence of enough long-term valve durability
data, accurate structural simulations and computational modeling become an integral part
of the evaluation. Computational simulations can play a pivotal role in design and
development of prosthetic heart valves considering appropriate material properties and
boundary conditions, especially TAVs, by reducing the need to perform expensive preclinical tests.
Increased mechanical stress and flexural deformation on TAV leaflets may lead to
accelerated tissue degeneration and diminished long-term durability (Ferrans et al. 1978a,
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Levy et al. 1983, Sacks 2001, Sacks and Schoen 2002a, Schoen and Levy 1999a, Schoen
et al. 1985, Thubrikar et al. 1983). Therefore, proper evaluation of the leaflet stress and
strain distributions is required for further assessment of the TAVs long-term durability and
to develop the next generation of heart valve prostheses. Numerous computational models
have been developed to determine stress and strain distribution of the bioprosthetic heart
valve leaflets under physiological loading conditions (Abbasi et al. 2016, Gunning,
Vaughan, and McNamara 2014, Hsu et al. 2015, Martin and Sun 2015, Abbasi and Azadani
2015, Abbasi and Azadani 2017, Li and Sun 2010). These studies showed that minimizing
the peak stress within a bioprosthesis leaflets is very crucial to maximize the long-term
durability of a tissue heart valve. Therefore, the optimal valve designs in which the peak
stress is reduced may provide improved long-term durability (Vesely 2003). Special
considerations need to be made for minimizing the peak stress within TAVs leaflets.
Incomplete TAV expansion, reductions in the thickness of TAV leaflets and leaflets
geometry must be considered in our computational simulations to improve the long-term
durability of TAVs. In addition, in computational modeling, considering accurate
constitutive models is of the utmost importance to precisely capture mechanical properties
of soft tissue and biomedical materials (Humphrey 2003).
1.7 Objectives
The objective of this study was to obtain accurate material properties of soft tissue
employed in bioprosthetic heart valves and to develop an automatic computational
framework to optimize the TAV leaflet shape under physiological loading conditions. In
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addition, the impact of incomplete TAV expansion and thickness reduction on leaflet stress
and strain distribution was assessed in this study.
To address the goals of this study in the development of TAVR, this dissertation is
structured as follows: In chapter 2, computational simulations were developed to determine
the impact of incomplete TAV stent expansion on TAV leaflet stress and strain
distributions. The computational simulation results of incompletely expanded TAVs were
compared to fully-expanded circular TAVs. In chapter 3, inverse FE methods were utilized
to determine three-dimensional anisotropic mechanical properties of bovine pericardial
leaflets of a surgical bioprosthetic heart valve under physiological loading condition. In
chapter 4, the main objective of this chapter was to use finite element (FE) simulation to
determine the impact of leaflet thickness on TAV leaflet stress and strain distribution under
dynamic loading condition. In chapter 5, using a high-resolution three-dimensional digital
image correlation (DIC) system, a side-by-side comparison of leaflet displacement and
strain fields of three commonly used bioprosthetic heart valves: (i) Carpentier-Edwards
PERIMOUNT Magna surgical bioprosthesis, (ii) Medtronic CoreValve, and (iii) Edwards
SAPIEN 3 was performed. In chapter 6, we developed a non-invasive material
characterization framework using integrated experimental and numerical methods to
determine mechanical properties of soft tissue employed in bioprosthetic heart valves.
Accordingly, I characterized three-dimensional anisotropic mechanical properties of
leaflets used in two commercially available TAVs (i.e., Edwards SAPIEN 3 and Medtronic
CoreValve), and compared the results to that of a commonly used and well-examined
surgical bioprosthesis (i.e., Carpentier-Edwards PERIMOUNT Magna aortic heart valve).
11

In addition, the present dissertation provides a reliable approach to compare leaflet stress
distribution among different bioprostheses under physiological loading condition. In
chapter 7, we developed an automatic optimization framework to assess the impact of 3D
leaflet shape on TAV maximum stress under dynamic physiological loading conditions. In
Chapter 8, some conclusions and suggestions for future researches were presented.
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CHAPTER 2: INCOMPLETE TRANSCATHETER AORTIC VALVE EXPANSION
2.1 Introduction
Although TAV manufacturers use a similar biologic leaflets as surgical bioprostheses
and therefore it would be expected to degenerate via similar mechanisms, TAV design and
implantation configuration are substantially different than surgical bioprostheses (RodesCabau 2012, Bourantas and Serruys 2014). Unlike surgical valves, the degree of TAV
expansion varies from patient to patient and depends upon annulus size and specific
calcified valve geometry (Delgado et al. 2010). Furthermore, the current guidelines for
TAVR are to upsize the TAV relative to the native annulus to secure the device and
minimize paravalvular leakage. The range of annulus size for TAVR suggests that not all
patients will achieve complete TAV expansion to the manufactured size, and some degree
of incomplete stent expansion may exist (Binder et al. 2013, Schultz et al. 2009). Such
alterations in the degree of stent expansion may lead to distorted leaflet cooptation which
over time can negatively influence long-term durability.

The impact of incomplete

TAV expansion on leaflet stress distribution and ultimately long-term valve durability are
not known. The objective of this chapter was to determine the impact of incomplete TAV
stent expansion on TAV leaflet stress and strain distributions. Increased mechanical stress
and flexural deformation on TAV leaflets may lead to accelerated tissue degeneration and
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diminished long-term durability (Ferrans et al. 1978a, Levy et al. 1983, Sacks 2001, Sacks
and Schoen 2002a, Schoen and Levy 1999a, Schoen et al. 1985, Thubrikar et al. 1983). In
this chapter, computational simulation results of incompletely expanded TAVs were
compared to fully-expanded circular TAVs.
2.2 Materials and Methods
2.2.1 Transcatheter aortic valve
A 23mm TAV was created based on the Edwards SAPIEN XT valve design (Fig. 2.1).
Three leaflets were cut from a bovine pericardium patch (Edwards Lifesciences, Irvine,
CA). The lateral sides of the leaflets were sutured together and then the leaflets were
sutured at the base to a Dacron Sheet. A cylindrical stainless-steel stent (height 14 mm and
thickness 0.34mm) was dilated to an external diameter of 23mm to hold the Dacron sheet
and leaflets. The 23mm TAV was crimped and balloon-expanded to diameters ranging
from 18 to 23mm in 1mm increments. A pre-drilled acrylic template was used to precisely
expand the valve to the desired diameters (Fig. 2.2). TAV leaflet geometry was then
obtained using NextEngine 3D Laser Scanner. Subsequently, surface reconstruction was
performed using RapidWorks and SOLIDWORKS packages (See Fig. 2.3).
2.2.2 Biaxial testing system
A planar biaxial stretching system (CellScale, Waterloo, Canada) was used to
determine mechanical properties of the bovine pericardium patch (Fig. 2.4). Three square
samples were cut from the pericardium patch. Sample orientation was aligned such that
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Figure 2.1: (Left) Edwards SAPIEN XT valve. (Center and right) Side and top view of
homemade 23mm transcatheter aprotic valve; leaflet geometry was based on the SAPIEN
XT valve design, adapted from (Abbasi and Azadani 2015).

Figure 2.2: Pre‐drilled acrylic template used to expand the TAV to the desired diameters,
adapted from (Abbasi and Azadani 2015).

Figure 2.3: Overview of making a 3D geometry and mesh for FEM model.
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Figure 2.4: Planar biaxial stretching system used to determine mechanical properties of
bovine pericardium, adapted from (Abbasi and Azadani 2015).
the circumferential edge of the square samples was parallel to the free edge of the TAV
leaflets. The circumferential and longitudinal directions were considered as x and y
directions, respectively. Specimen dimensions and thicknesses were measured using
Mitutoyo Digital caliper and were stored in normal saline solution.
To obtain mechanical properties, the specimens were mounted on the biaxial system
using a set of four CellScale BioRakes. The biaxial system equipped with two Honeywell
1,000g load cells located on two orthogonal arms. The load cells were zeroed after
mounting the specimen. A temperature-controlled normal saline bath heated to 37°C
provided a physiological environment. The top sides of tissue samples were sprinkled with
graphite to create a textured surface for strain measurements. Real-time displacement of
the graphite markers was obtained at a rate of 15Hz using a camera placed over the top
16

surface.

Specimens were examined using the following equibiaxial displacement-

controlled protocol. First, ten preconditioning cycles of 10% true strain were applied on
both axes at 0.5Hz. Subsequently, each specimen was stretched to 100% strain on both
axes with a 5s stretch and a 5s recovery. Furthermore, CellScale LabJoy image tracking
software was used to obtain strain maps of the samples.
2.2.3 Constitutive modeling
Soft tissues are mostly comprised of water (Fung 1993); therefore, the pericardium
samples were considered to be incompressible. Planar forces (Fxx, Fyy) measured by the
two load cells were used to calculate Cauchy stresses (Txx, Tyy) in the circumferential and
longitudinal directions.


(2.1a)



(2.1b)
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where t0 is tissue thickness in the zero-stress state, and λ= /  is stretch ratio represents the
ratio of deformed tissue length ( ) to resting length (  ). Components of Green strain (E)
were calculated using the following equations:


(2.2 a)



(2.2 b)
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A four parameter Fung’s exponential strain energy function was fitted to the stressstrain data (Fung, Fronek, and Patitucci 1979)
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where Ex and Ey are the Green strains in x and y directions, respectively. cxx, cyy, cxy, and c
are the material constants. Cauchy stresses can be obtained by the following equations:
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A Levenberg-Marquardt least squares algorithm in MATLAB (v8.1.0.604) was used
to fit the Fung’s strain energy to the experimental data.
Although arm displacement rates were set equal for both circumferential and
longitudinal directions, strain applied to the center of the specimen was not exactly equal
in the two directions, mainly due to initiation and propagation of tears in the tissue at the
boundaries where tungsten wires were anchored (Fig. 2.4).

Therefore, stress-strain

relationships in the equibiaxial strain state (Exx=Eyy=E) were obtained as:
#$%&

= (2 + 1)' +  ( !")' + 

+ 2 (  *

(2.5a)

 #$%& = (2 + 1)' +  ( !")' + 

+ 2 (  *

(2.5b)

where the superscript equi denoted equibiaxial condition. The stress-strain curves
converted to the equibiaxial stretch condition, and the anisotropic index, the difference in
stiffness between the circumferential and longitudinal directions divided by the average
stiffness, was calculated for each sample (Matsumoto et al. 2009). In the biaxial stretching
system, although arm displacement rates were set equal for both circumferential and
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longitudinal directions, strain applied to the center of the specimen was not exactly equal
in the two directions. This is mainly due to initiation and propagation of tears due to stress
concentration at the boundaries where BioRake tungsten wires are anchored, as shown in
the Fig. 2.4. Therefore, we obtained stress-strain relationships in the equibiaxial strain state.
2.2.4 Finite element (FE) modeling
FE modeling was performed using ABAQUS/Explicit package (Dassault Systemes
Simulia Corp., RI, USA). In the simulations, leaflets were only modeled, and the stent was
considered to be rigid. IGES format of the leaflets were imported into HyperMesh (Altair
Engineering, Troy, MI), and leaflet geometry was discretized with mapped mesh (See Fig.
2.3). The mesh was then imported to ABAQUS to perform a large deformation analysis.
S4 shell elements with general frictionless contact were used to discretize the valve
geometry. Element type S4 is a fully integrated finite-membrane strain shell element and
it does not have hourglass modes in either the membrane or bending response of the
element. Therefore, we used element type S4 because the element does not require
hourglass control and it improves stress calculation accuracy.
A mesh of approximately 8,000 elements was enough to assure that the results are
independent of mesh density. A transvalvular pressure waveform measured from repeated
in-vitro tests conducted in our custom-built pulse duplicator (BDC Labs, Wheat Ridge,
CO) was applied to the leaflets (Fig. 2.5). The pulse duplicator input parameters were
matched with ISO-5830 and FDA standards for testing heart valves: heart rate of 70
beats/min, mean aortic pressures of 100 mm-Hg, and cardiac outputs 5 L/min. In the
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dynamic FE analysis, density of 1,100 kg/m3 was used for the leaflets(Jermihov, Jia, Sacks,
Gorman, Gorman III, et al. 2011, Kim et al. 2006).
It has been observed that neglecting viscous damping in modeling of bioprosthetic
valves may cause instability in FE models (Jermihov, Jia, Sacks, Gorman, Gorman III, et
al. 2011, Kim et al. 2006). Therefore, to mimic viscous damping effects of surrounding
fluid, a Rayleigh damping coefficient of α=20000 1/s was considered in the simulations
(Jermihov, Jia, Sacks, Gorman, Gorman III, et al. 2011, Kim et al. 2006). Two cardiac
cycles were simulated to guarantee cycle invariance.

Figure 2.5: The variation in pressure in the left ventricle (red dashed line) and the aorta
(blue solid line) over two cardiac cycles. The wave pressure (green dash-dot line) is defined
as the pressure difference between the left ventricle and the aorta, adapted from (Abbasi
and Azadani 2015).
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2.3 Results
2.3.1 Biaxial stretching data
Square samples of consistent size were cut from the bovine pericardium patch, and
length and thickness of each sample are shown in Table 2.1. Experimental raw data
obtained from biaxial testing of the three specimens are shown in Fig. 2.6. Stress-strain
data were fit to the Fung’s strain energy function and material constants for each specimen
are shown in Table 2.1. In addition, using Eq. (2.5), the stress-strain curves were converted
to the equibiaxial stretch condition. As shown in Fig. 2.7, the difference between the
equibiaxial stress-strain curves in the circumferential and longitudinal directions for each
one of the samples was found to be minimal which is 19%. It appears that the entire
extracellular matrix of the bovine pericardium is highly bonded due to chemical fixation
and anti-calcification treatment, and therefore the tissue behaves nearly like an isotropic
material over the examined strain range.
As a result, in the computational modeling, TAV leaflets were assumed to be isotropic
nonlinear hyperplastic material, and a fourth-order reduced polynomial strain-energy
function as shown below was fitted to the average curve of each sample:
 = ∑,&-

̅ − 3)&
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(2.6)

Table 2.1: The Dimensions of bovine pericardium specimens and coefficients of Fungstrain energy function fitted to the raw data.
Specimen
Number

Thickness
(mm)

Length
(mm)

C(kPa)

cxx

cyy

cxy

Anisotropic
index

1

0.433

13.36

133.84

4.48

2.53

12.16

0.124

2
3

0.426
0.430

13.34
13.35

74.43
42.69

10.36
36.36

6.28 23.70
25.95 21.48

0.127
0.198
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Figure 2.6: Raw biaxial data of three squared specimens cut from bovine pericardium in
the circumferential (filled marks) and longitudinal (blank marks) directions, adapted from
(Abbasi and Azadani 2015).

Figure 2.7: Raw data were converted to equibiaxial stretch condition (dashed lines:
circumferential, dotted lines: longitudinal, and solid lines: average), adapted from (Abbasi
and Azadani 2015).
 = ∑,&-
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where Ci0 are constants and .̅ is the first principal invariant of the left Cauchy–Green
deformation tensor.
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In the simulations, the average mechanical property of specimen number 1 was
considered as material property of the three TAV leaflets. In this way, our simulations
would capture the highest stress levels that may exist in TAV leaflets. The coefficients of
the reduced polynomial strain-energy function fitted to the average curve of specimen
number 1 are shown in Table 2.2.
2.3.2 Leaflet stress and strain distributions
The maximum principal stress and strain distributions of the 23mm TAV expanded
to diameters ranging from 18 to 23mm are plotted in Fig. 2.8 and Fig. 2.9 at the peak of
systole and early in the diastole. As shown in the figures, TAV leaflet stress and strain
distributions were dependent on the diameter of the inflated TAV.

After complete

expansion of the TAV to 23mm, high stress regions were observed primarily in the
boundary edge during systole, and the maximum principal stress reached 1.04MPa in the
fully-open position. During diastole, however, high stress regions were observed primarily
in the commissures, and the maximum stress reached 2.52MPa, early in diastole right after
complete valve closure. In addition, the maximum principal logarithmic strain exhibited a
similar distribution during valve opening and closing. The peak strain value reached to
0.28 at the boundary edge in the fully-open position, and the peak strain value reached to
0.36 at the commissures in the diastole.
Table 2.2: Coefficients of fourth-order reduced polynomial strain-energy function fitted to
the average curve of specimen number 1.
C10

C20

C30

C40

1.56941E+5

8.59024E+5

-6.50847E+5

5.59565E+6
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Figure 2.8: (Left column) 23mm TAV expanded to diameters ranging from 18 to 23 mm
in 1 mm increments. (Middle column) 1st principal stress of TAV leaflets (MPa) in the
fully-opened position. (Right column) 1st principal stress of TAV leaflets (MPa) in the
diastole, adapted from (Abbasi and Azadani 2015).
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Figure 2.9: (Left column) 23mm TAV expanded to diameters ranging from 18 to 23 mm
in 1 mm increments. (Middle column) 1st principal logarithmic strain of TAV leaflets in
the fully-opened position. (Right column) 1st principal strain of TAV leaflets in the
diastole, adapted from (Abbasi and Azadani 2015).
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As presented in Fig. 2.8 and Fig. 2.9, incomplete expansion of TAV for 2mm or more
induced localized high stress and strain regions within the leaflets. Incomplete expansion
of the 23mm TAV to diameters of 21 and 20mm induced sharp bending at the commissures
and consequently created localized high stress regions (Fig. 2.8).

After incomplete

expansion of the 23mm TAV to diameters of 21 and 20mm, the maximum principal stress
in the fully-open position reached to 1.28 and 1.33MPa, respectively; however, early in the
diastole, the maximum principal stress reached to 3.53 and 4.49MPa, respectively.
Furthermore, the maximum principal logarithmic strain after incomplete expansion of the
23mm TAV to diameters of 21 and 20mm reached to 0.31 and 0.56 respectively in the
fully-open position and reached to 0.42 and 0.57 respectively in the diastole.
In contrast, incomplete expansion of the 23mm TAV to diameters of 19 and 18mm
shifted high stress and strain regions from the commissures to the belly region in the
diastole. Expansion of the 23mm TAV diameters to 19 and 18mm induced sharp leaflet
bending within the belly of the TAV leaflets and consequently created pockets of high
stress regions in the belly region in the diastole (Fig. 2.8). The maximum stress within the
belly region was reached to 2.60 and 3.00MPa after incomplete expansion of the 23mm
TAV to diameters of 19 and 18mm, respectively. In the fully-open position, however, the
maximum stress was observed in the vicinity of boundary edges, and the maximum stress
reached to 1.06 and 1.58MPa, respectively. The maximum principal logarithmic strain
showed similar distribution to the maximum principal stress during valve opening and
closing. After incomplete expansion of the 23mm TAV to diameters of 19 and 18mm, the
maximum principal logarithmic strain reached to 0.35 and 0.40, respectively early in the
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diastole, and during systole, the maximum principal logarithmic strain reached to 0.28 to
0.35, respectively.
In diastole, as shown in Table 2.3, the average principal stress of the commissures
was increased as the post-inflation diameter increased. In contrary, the maximum principal
stress in the belly region was decreased as the post-inflation diameter increased.
Furthermore, incomplete expansion of the 23mm TAV to diameters of 21 and 20mm
induced sharp bending at the commissures and consequently created localized high stress
regions within the commissures as presented in Table 2.3. However, expansion of the
23mm TAV diameters to 19 and 18mm induced sharp leaflet bending within the belly of
the TAV leaflets and created pockets of high stress regions.
2.4 Discussion
2.4.1 Summary
In this chapter, we examined the impact of incomplete TAV stent expansion on leaflet
stress and strain distributions to understand the impact of oversizing on deformation and
mechanical performance of TAV leaflets. Through dynamic simulations of a 23mm TAV
expanded to diameters ranging from 18 to 23mm, we found that the maximum principal
stress was significantly higher in the diastolic phase of cardiac cycle than the systolic phase.
Furthermore, we found that TAV leaflet stress and strain distributions were dependent on
the diameter of the inflated TAV. After complete expansion of the TAV to 23mm, high
stress regions were observed primarily in the commissures during the diastole. However,
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Table 2.3: 1st principal stress of 23mm TAV leaflets expanded to diameters ranging from
18 to 23 mm in the diastole.
TAV inflated diameter

23mm

22mm

21mm

20mm

19mm

18mm

Average principal stress of all
the commissures (MPa)

1.56

1.32

1.23

1.19

0.87

0.37

Maximum 1st principal stress in
the commissure region (MPa)

2.52

2.31

3.53

4.49

1.91

1.83

Maximum 1st principal stress in
the belly region (MPa)

1.16

1.24

1.36

2.26

2.60

3.00

2-3mm incomplete TAV stent expansion induced localized high stress regions within the
commissures due to sharp tissue bending at the commissures. The peak stresses were
increased by 40.1% and 78.2% after incomplete expansion of the 23mm TAV to diameters
of 21 and 20mm, respectively. In contrast, 4-5mm incomplete stent expansion induced
localized high stress regions within the belly of the TAV leaflets. The peak stresses were
increased by 124.1% and 158.6% within the belly region after incomplete expansion of the
23mm TAV to diameters of 19 and 18mm, respectively. Increased mechanical stress and
flexural deformation on TAV leaflets may lead to accelerated tissue degeneration.
2.4.2 Oversizing in TAVR procedure
In TAVR procedure, valve oversizing is crucial to achieve proper anchoring.
Currently, Edwards SAPIEN valve and Medtronic CoreValve are widely available and
used. TAV size recommendations are based on native valve annulus size, as measured by
transesophageal echocardiography (TEE) or computed tomography (CT). According to
Edwards Lifesciences instructions for use, 23mm Edwards SAPIEN XT valve is
recommended for native valve annulus size of 18-22mm measured by TEE, and native
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valve annulus area of 314-415mm2 measured by CT. On the other hand, CoreValve is
slightly more oversized than SAPIEN valve. Based on Medtronic instructions for use,
23mm CoreValve is recommended for annulus size of 18-20mm, and 26mm CoreValve is
recommended for annulus size of 20-23mm. The range of annulus size for TAVR suggests
that not all patients will achieve complete TAV expansion to the manufactured size, and
some degree of incomplete stent expansion may exist. Incomplete stent expansion has
been commonly observed following TAVR with Medtronic CoreValve in native calcified
aortic valves, and following TAVR with Edwards SAPIEN valve within degenerated
stented bioprostheses, the valve-in-valve procedure (Bapat et al. 2013, Jilaihawi et al. 2011,
Schultz et al. 2009, Willson et al. 2012). In native calcified valves, incomplete expansion
of the Medtronic CoreValve stent is common and has been observed in 62% of patients
undergoing TAVR (Jilaihawi et al. 2011, Schultz et al. 2009). Nevertheless, incomplete
stent frame expansion has also been observed in TAVR with Edwards SAPIEN valves.
Willson et al. reported 8% of patients undergoing TAVR with SAPIEN valve in the study
cohort had under-expanded stent frame (Willson et al. 2012). Incomplete expansion of
SAPIEN frame is typical because of the existence of highly calcified native leaflets,
inaccuracy of annulus sizing prior to TAVR procedure, or specific valve anatomy (e.g.
bicuspid aortic valve). In the contrary to native valves, in the valve-in-valve procedure
within degenerated bioprosthetic valves, incomplete stent expansion is more common in
TAVR with Edwards SAPIEN valves. This is due to the fact that SAPIEN valves are
implanted within the rigid bioprosthetic frame, in contrary to the supra-valvular positioning
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of CoreValve. Therefore, incomplete stent expansion is a common phenomenon in both
Edwards SAPIEN valve and Medtronic CoreValve Revalving system.
Unlike surgical stented bioprosthetic valves where leaflets are attached to a rigid
frame and their motion is highly consistent, optimal TAV function requires full circular
deployment of the valve to its nominal dimensions(Azadani, Jaussaud, Matthews, Ge, et
al. 2009, Azadani and Tseng 2011, Gunning, Vaughan, and McNamara 2014). Underexpanded TAVs will function suboptimally with impaired coaptation of the leaflets and
increased valvular pressure gradient (Azadani et al. 2011, Azadani, Jaussaud, Matthews,
Chuter, et al. 2009). It has previously determined that incomplete TAV expansion due to
oversizing negatively impacts valvular hemodynamics, leading to increased pressure
gradient and transvalvular energy loss (Azadani et al. 2010). Therefore, fully-expanded
circular stent deployment is essential to achieve optimal hemodynamic outcomes following
TAVR. In this chapter, we assumed an identical pressure wave across all the simulations
for consistency. However, incomplete TAV expansion leads to increased transvalvular
pressure gradients, and increased valvular gradients will induce even higher localized
stresses on leaflets of the under-expanded TAVs during systole.
The degree of TAV expansion varies from patient to patient based on annulus size and
specific calcified valve geometry. As a result, non-circular eccentric stent deployment may
also occur in TAVR patients (Delgado et al. 2010, Morganti et al. 2014, Schultz et al. 2009,
Zegdi et al. 2008). Sun and Siroios (Sun, Li, and Sirois 2010) have shown that distorted,
elliptical shape of TAVs induced a significant increase in leaflet peak stresses and strains
compare to those of fully-expanded circular TAVs under the same loading conditions. They
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proposed a FE model to simulate elliptical bioprosthetic valve deformation under quasistatic loading condition by applying a uniform pressure of 120mmHg to the leaflets. They
reported that maximum stress and strain of a distorted TAV with an elliptical eccentricity
of 0.68, increased significantly by 143% and 17%, respectively, as compared to a fullyexpanded circular TAV. Clinical importance of TAV under-expansion or eccentricity and
their impact on the long-term valve durability is unknown. There is indirect evidence,
observed in stentless surgical bioprostheses, to suggest that valve distortion may lead to
accelerated calcification and fibrosis in an animal model (Mohammadi et al. 2006, van
Nooten et al. 1999). Therefore, increased mechanical stress due to incomplete or eccentric
stent deployment may lead to diminished long-term durability.
2.4.3 Study limitations
In this chapter, initial leaflet geometry was based on a homemade TAV. Although,
the TAV leaflet geometry was similar to SAPIEN XT, by using precise leaflet geometry of
SAPIEN valve or CoreValve, accurate leaflet stress and strain distributions of the two
devices that are widely used in clinics can be obtained. In addition, the effects of crimping
on the mechanical properties of tissue were not considered in this FE analysis. Alavi et al.
(Alavi, Groves, and Kheradvar 2014c) reported the crimping may induce structural damage
to bovine pericardial leaflets. Furthermore, the three TAV leaflets were assumed to be
isotropic nonlinear hyperplastic material. Although tissue anisotropy was minimal, a
nonlinear anisotropic material model may provide more accurate simulation results.
Alteration in the material properties induces significant changes in the mechanical behavior
of the leaflets, as highlighted by Auricchio et al. (Auricchio et al. 2014) . Finally, viscous
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damping was implemented in the FE simulations to mimic surrounding fluid. However, a
more accurate simulation may involve fluid–structure interaction (FSI) simulation.
2.5 Conclusions
In summary, computational models were developed to study the impact of incomplete
TAV stent expansion on leaflet stress and strain distributions. We found that TAV leaflet
stress and strain distributions were dependent on the diameter of the inflated TAV. We
found that 2-3mm incomplete TAV stent expansion induced localized high stress regions
within the TAV commissures, while 4-5mm incomplete stent expansion induced localized
high stress regions within the belly of the TAV leaflets during the diastolic phase of the
cardiac cycle. In TAVR, valve oversizing is essential to secure the valve and prevent
paravalvular aortic regurgitation. However, if oversizing leads to incomplete expansion of
the stent, it will induces localized high stress regions within the TAV leaflets which
overtime may lead to premature tissue degeneration.
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CHAPTER 3: MATERIAL CHARACTERIZATION OF HEART VALVE TISSUE
3.1 Introduction
Design and development of the life sustaining implantable medical devices such as
heart valves in the current regulatory framework require extensive and expensive preclinical and clinical testing. The existing process limits opportunities to thoroughly refine
current designs, and explore novel high-risk, high-payoff ideas (Keefe et al. 2010).
However, in the past few years, the role of computational modeling is becoming
increasingly important in design and verification of medical devices. Computational
modeling provides a framework for quantitative description of device function and
provides greater consistency and predictability in the development of new devices.
Furthermore, computational modeling can yield significant cost savings by mitigating the
need to perform time consuming bench-top and pre-clinical animal testing. As a result,
computational modeling and simulations are becoming an integral part of research and
development in medical device industry, considering that the U.S. Food and Drug
Administration (FDA) and CE Mark regulatory requirements are a major driving force
behind it (Stewart 2013).
In computational modeling, considering accurate constitutive models is of the utmost
importance to precisely capture mechanical properties of soft tissue and biomedical
materials (Humphrey 2003). Constitutive models are needed to accurately predict and
33

simulate mechanical response of biomedical materials under a verity of multi-axial loading
conditions that may exist under physiological conditions. However, lack of comprehensive
three-dimensional material models limits the utility and effectiveness of computational
models in research and development of medical devices. Some of the reasons accountable
for the absence of comprehensive three-dimensional soft tissue constitutive models are: (1)
Majority of experimental testing used to estimate material parameters such as in-plane
biaxial testing cannot capture the out-of-plane displacements of soft tissue, required to
determine 3D anisotropic mechanical properties of soft tissue (Holzapfel and Ogden 2009).
In addition, technical difficulties in interpreting biaxial test results have been previously
reported that may impact the experimental outcome (Eilaghi et al. 2009, Nolan and
McGarry 2016, Waldman and Lee 2002), (2) Biological soft tissues are viscoelastic in
nature and often approximated as pseudo-hyperelastic models; however, the pseudohyperelastic models commonly fitted to experimental data that were not collected at strainrates comparable to physiological conditions.
Extensive intra-specimen and inter-specimen variations exist in mechanical properties
of soft tissue; therefore, mechanical properties of examined materials in experimental
setting may be significantly different from the actual materials used in the implanted
devices.

Thus, using optimized material coefficients to represent specimen-specific

behavior is crucial in computational modeling and simulations. Inverse finite element (FE)
analysis is a valuable tool that can be used to accurately estimate mechanical properties of
heart valve tissues on subject-specific basis. The procedure is a numerical approach in
which an optimization algorithm is coupled with a FE method to find optimal values for a
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set of parameters such as material parameters in a constitutive equation. In the optimization
process, experimental data is often used as reference input to the parameter estimation
algorithm. In recent years, in particular with the advent of transcatheter aortic valve
replacement for the treatment of patients with aortic stenosis, utilization of computational
models is an emerging trend for demonstrating the effectiveness of new valve designs
(Kheradvar, Groves, Falahatpisheh, et al. 2015). Currently, the commercially approved
transcatheter heart valve leaflets are made from chemically treated bovine or porcine
pericardium (Kheradvar, Groves, Goergen, et al. 2015). In addition, chemically treated
bovine pericardium has been extensively used in the fabrication of surgical bioprostheses.
It has been demonstrated that chemically treated bovine pericardium is an anisotropic
biocomposite material (Sacks and Chuong 1998, Zioupos, Barbenel, and Fisher 1992), with
intra-specimen and inter-specimen variability and distinct collagen fiber architecture
(Sacks, Chuong, and More 1994). During the past few decades, a number of computational
studies have attempted to determine stress distribution of valve leaflets and correlate high
flexural stresses during valve opening and high tensile stresses during valve closure to
regions of tissue degeneration. However, the accuracy of the simulations may be limited
due to the use of simplistic isotropic or simplified non-subject-specific anisotropic material
models for bovine pericardial leaflets.
The main objective of this chapter was to use inverse FE methods to determine threedimensional anisotropic mechanical properties of bovine pericardial leaflets of a surgical
bioprosthetic heart valve under physiological loading condition. The FE simulations were
validated using experimental in-vitro measurements, and the impact of different
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generalized Fung-elastic constitutive models (generalized anisotropic vs. orthotropic) in
ABAQUS software was investigated on leaflet deformation and stress distribution.
Furthermore, the Rayleigh damping coefficient that was introduced to the FE simulations
to simulate viscous damping effects of surrounding fluid was assessed in the inverse
parameter estimation. Lastly, this chapter presents an approach for utilizing commercial
FE software packages for quantitative description of heart valve function under
physiological loading conditions and mitigating the need to perform time consuming
bench-top and pre-clinical animal testing.
3.2 Materials and Methods
3.2.1 Theoretical Background
3.2.1.1 Constitutive Modeling
A constitutive law should approximate physical behavior of soft tissue under specific
conditions of interest.

Biological soft tissues are viscoelastic in nature, and their

mechanical behavior is dependent on the history of deformation. However, biological soft
tissue are often approximated as pseudo-hyperelastic materials (Fung 2013a). A
hyperelastic material is defined as a subclass of elastic materials in which there exists a
strain-energy function 1 which is exclusively a function of the deformation gradient

tensor 2.
3=

45(2)

(3.1)
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Where 3 denotes the first Piola-Kirchhoff stress tensor which is a measure of the force
acting on the deformed configuration per unit undeformed area.
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The strain-energy function can also be expressed as a function of Green-Lagrange
strain tensor 6 in the form of
7=

45(6)

(3.2)
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Herein, 7 is the second Piola-Kirchhoff stress tensor. The second Piola-Kirchhoff
stress tensor can be defined in another way
7 = 8 29 :29;

(3.3)

where : is the Cauchy stress tensor, and 8 = det 2 is the Jacobian of the deformation.
Cauchy (or true) stress is a measure of force per unit area in the deformed configuration.
For additional information regarding strain and stress tensors, the reader is referred to
(Holzapfel 2000, Lai et al. 2009).
Soft tissues are primarily comprised of water and therefore have negligible
permeability (Fung 2013a). Materials that keep their volume constant through deformation
are characterized by incompressibility constraint 8 = 1. For additional information
regarding enforcing incompressibility constraint on the strain energy function, the reader
is referred to (Fung and Tong 2001, Sun and Sacks 2005b).
3.2.1.2 Elasticity Tensor
An elasticity tensor ℂ describes properties of the continuum and shows how variations
in strain will affect the stress tensor.
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ℂ = 46

(3.4)
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Elasticity tensor is a tensor of rank four with 81 components. However, the number of
coefficients can be reduced to 21 independent components by making arguments of
symmetry (Holzapfel 2000, Lai et al. 2009). It is also important to note that the convexity
of strain energy functions should be always satisfied to guarantee the stability of elastic
body equilibrium while deforming. If the elasticity tensor ℂ is positive definite, then the

strain energy function will be convex. The elasticity tensor ℂ is said to be a positive definite
if (1) all diagonal elements are positive; (2) the determinant of ℂ is positive, and (3) its

inverse exists, and is symmetric and positive definite (Holzapfel 2000).
3.2.1.3 Generalized Fung Hyperelastic Constitutive Model
The Fung strain-energy function, introduced more than three decades ago, has been
shown to properly describe the nonlinear mechanical behavior of many biological soft
tissue (Fung, Fronek, and Patitucci 1979). A generalized three-dimensional Fung strainenergy function

proposed

by Humphrey (Humphrey 1995)

is

available in

ABAQUS/Explicit in the form of
1=

@ A
1 8#  − 1
( − 1) + (
− ln 8# )
2
B
2

(3.5)

where 1 is the strain energy per unit of reference volume. B and @ describe the

temperature-dependent material parameters, 8# stands for the elastic volume ratio which is
equal to 8 in the absence of thermal strains, and A is given by
A = 6: (F6)

(3.6)
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where F is a non-dimensional symmetric fourth-order tensor of anisotropic material

constants, and 6 is the Green-Lagrange strain tensor, under the assumption of tissue
incompressibility.
Considering incompressibility assumption (8# = 1), the Fung strain energy function
is reduced to
1=

@ A
( − 1)
2

(3.7)

If F is positive definite, then 1 is strictly convex, and the numerical solution will be

stable. The number of components of F that must be determined is similar to the elasticity

tensor ℂ. ABAQUS supports generalized anisotropic and orthotropic forms of the

generalized Fung model, and therefore the number of independent components of F has to

be specified based on the level of anisotropy: 21 for the fully anisotropic and 9 for the
orthotropic materials.
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(3.8)

3.2.2 Biaxial Testing System
To characterize mechanical properties of bovine pericardium of a surgical
bioprosthetic valve based on the generalized Fung constitutive model using inverse FE
simulations, appropriate initial estimate values were needed. To obtain the initial values, a
bovine pericardial patch was obtained from Edwards Lifesciences Inc. and a planar biaxial
stretching device (CellScale Biomaterials Testing, Waterloo, Canada) was used to
determine the patch in-plane mechanical properties (Fig. 3.1A). Details of the biaxial
testing procedure have been previously described in chapter 2. Briefly, three square
samples were cut from the pericardium patch for biaxial testing. The specimens were
mounted on the biaxial stretching system by using a set of four CellScale BioRakes. A
normal saline bath heated to 37° C provided a physiological environment. The top sides
of specimens were sprinkled with graphite to create a textured surface for strain
measurements. Samples were tested over a large strain range using the following
equibiaxial displacement-controlled protocol. First, ten preconditioning cycles of 10% true
strain were applied on both axes at 0.5 Hz. Subsequently, each specimen was stretched to
100% strain on both axes with a 5 s stretch time. Real-time displacement of the graphite
markers was obtained using a camera placed over the top surface at a rate of 15 Hz.
CellScale LabJoy image tracking was used to capture displacement field (Fig. 3.1A).
Relative movements of the center-element nodes were used to calculate deformation
gradient and green strain in MATLAB (v8.1.0.604, Natick, MA). To analyze kinematics,
we restricted our analysis to planar homogenous deformations in the form of

40

! =  b + c b

! = c b +  b

(3.9)

!d = d bd

(B)

Figure 3.1: (A) Planar biaxial stretching system used to determine mechanical properties
of bovine pericardium, and (B) The raw data were fit to two-dimensional Fung constitutive
model (solid lines: Fung model with in-plane shear strains and dashed lines: Fung model
without in-plane shear strains), adapted from (Abbasi et al. 2016).
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where b& and !& are material points in the reference configuration and deformed

configuration, respectively, & are the axial extension ratios and c& are measures of in-

plane shear. Since bovine pericardium has negligible permeability (8 = 1), the out-ofplane extension ratio was calculated as d = 1/(  − c c ).

In addition, data from load cells was used to determine stress during deformation.
Planar forces (f , f ) measured by the two load cells were used to calculate the non-zero

components of the first Piola-Kirchhof 3 stress (g , g ) in the two orthogonal directions.
g = j

hi

ℓ i

and

g = j

hl

(3.10)

ℓ l

where j is tissue thickness in the zero-stress state, and ℓ is the length of undeformed
tissue. For the biaxial planar homogeneous deformation, out of plane normal and shear
stresses were considered to be zero. Using the components of the first Piola-Kirchhof
stress, the associated second Piola-Kirchhof and Cauchy stress were calculated.
For constitutive modeling, Fung constitutive model was considered with full
expansion of quadric terms of Q to account for in-plane shear strains (Sacks 1999)



A = b E
+ b E
+ 2b E E + b E
+ 2b E E +

2b E E

(3.11)

The experimental data from the biaxial mechanical stretch testing was fitted to the twodimensional Fung model using a nonlinear regression interior-point algorithm in
MATLAB. Convexity of the constitutive model was enforced as descried previously(Sun
and Sacks 2005b). Since the regression algorithm is sensitive to the starting parameters,
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several wide-ranging initial starting guesses were used to obtain optimized material
parameters. In addition, to obtain initial estimate values for the orthotropic model, the
experimental data were fit to Fung constitutive model without in-plane shear strains.
3.2.3 In-Vitro Testing System
A custom-built pulse duplicator system (BDC Labs, Wheat Ridge, CO) was used for
functional testing of a 23mm Carpentier-Edwards bioprosthetic aortic valve (Fig. 3.2). The
pulse duplicator input parameters matched ISO 5840 and FDA standards for testing heart
valves: heart rate of 70 beats/min, mean atrial and aortic pressures of 10 and 100mmHg,
and cardiac output of 5 L/min. Recirculating fluid of 37% by volume glycerin solution in
normal saline solution was used as a blood analog fluid. Transvalvular pressure waveform
and flow rate were measured from repeated in-vitro tests. Furthermore, the leaflet motion
was captured by a Casio Ex-FH25 high-speed camera during the entire cardiac cycle at a
rate of 1000 frames per second. The images were digitized in MATLAB, and the center of
each leaflet was tracked and its distance with respect to the center of the valve was
calculated through the entire cardiac cycle.
To match the motion, shape, and deformation leaflet in the FE simulation with the
experimental measurements in the pulse duplicator, we didn’t filter transvalvular pressure
waveform were measured from repeated in-vitro tests and used the experimental raw data
in our simulations. Although the reproducing physiological hemodynamic conditions in
vitro pulse duplicator system was tried in our experiments, due to the lack of adequate
compliance in the cardiac chamber, the peak systolic transvalvular pressure obtained in the
experiment was higher than the physiological value. In most previous studies, to acquire
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physiological hemodynamic conditions, the transvalvular pressure waveforms obtained
from in-vitro tests were filtered.
3.2.4 Finite Element Modeling
Leaflet geometry of the 23mm Carpentier-Edwards bioprosthesis was obtained using
NextEngine 3D Laser Scanner (NextEngine, Inc., Santa Monica, CA).

Surface

reconstruction was performed using RapidWorks and IGES format of the leaflets were
obtained for FE simulations (See Fig. 3.4). For mesh generation, the leaflets were imported
to HyperMesh (Altair Engineering, Inc., Troy, MI), and the geometry was discretized using
a mapped mesh. The mesh was subsequently imported to ABAQUS/Explicit solver, and
S4 shell elements with a thickness of 0.513 mm were used to discretize the valve geometry.
Material orientation for each one of the elements was uniformly aligned parallel and normal
to the free edge of the leaflets using a home-made MATLAB script (See Fig. 3.5). Density
of the leaflets was considered to be 1,100 kg/m³ and bioprosthetic frame was considered to

Figure 3.2: Custom-built pulse duplicator system (BDC Labs, Wheat Ridge, CO)
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Figure 3.3: Custom-built pulse duplicator system (BDC Labs, Wheat Ridge, CO), and (B)
Bioprosthetic pressure and flow rate waveforms, adapted from (Abbasi et al. 2016).
be rigid and fixed. Furthermore, no boundary condition was applied to the upper edge of
the leaflets. Furthermore, the transvalvular pressure waveform obtained from the in-vitro
experiments was applied to the leaflets to model the dynamic loading. Moreover, a
Rayleigh damping coefficient n was introduced to the simulations to mimic viscous
damping effects of surrounding fluid.

Figure 3.4: Overview of making a 3D geometry for the 23mm Carpentier-Edwards
bioprosthesis.
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Figure 3.5: Material orientation axes defined in the circumferential (1-axis; blue), radial
(2-axis; green) and normal (3-axis; red) directions.
Note that the number of elements discretizing the leaflet geometry was chosen based
on the study of the independence of numerical solution, specifically the distribution of
principal stress contours on the leaflets, from the computational grid (Fig. 3.6). In these
simulations, leaflets were assumed to be isotropic nonlinear hyperplastic material, and a
fourth-order reduced polynomial strain-energy function. Details of the material model have
been previously described in chapter 2.
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3.2.3 Optimization Framework
We utilized a two-step global optimization technique to determine 3D mechanical
properties of the bioprosthetic leaflets as well as the Rayleigh damping coefficient. The
flowchart in Fig. 3.7 shows how the target parameters were determined. First, equi-biaxial
tensile test was simulated to obtain appropriate initial estimate values for the out-of-plane
material coefficients in both generalized anisotropic and orthotropic forms of the Fung
model. Considering the symmetry of the specimen geometry, only one quarter of the
specimen was simulated (Fig. 3.1A). Out-of-plane material coefficients of the specimen
were obtained by minimizing the error norm of displacement field between biaxial
measurements and FE simulations of the central element using particle swarm optimization
(PSO) method implemented in Isight (Simulia, Providence, RI). The optimization process
terminated when the change of the objective function is less than the set tolerance of 10-6.
Second, bioprosthetic leaflets were simulated and the material parameters obtained from
the previous step were used as initial estimate values in the second round of optimization.
In this step, the material parameters plus the viscous damping coefficient were optimized
using PSO method in Isight. Twenty-three and eleven input parameters were included in
the optimization procedure for generalized anisotropic (Fop&qrsrt&u , @ , and n) and

orthotropic (Frsvrsrt&u , @ , and n) Fung models, respectively. The middle point distance
of leaflets with respect to the center of the valve in the FE simulation was matched with
the experimental measurements as shown in Fig. 3.8A. To reduce computational cost, only
one leaflet motion was considered in the optimization procedure during the valve opening
in the systole. The optimization process terminated when the change of the objective
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Figure 3.6: Independence of the numerical FE solution from the computational grid. The
contours are showing the distribution of the maximum principal stress on the valve leaflets.
The difference in maximum stress and displacement during diastole between (B) and (C)
was less than 0.7%.
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function is less than the set tolerance of 10-6. Positive definiteness of elasticity tensor and
incompressibility constraint were imposed by the solver during the optimization iterations.
3.3 Results
3.3.1 Biaxial stretching data
Three square samples were cut from the bovine pericardium patch and stretched in the
biaxial testing machine. Length and thickness of each square sample are shown in Table
3.1. The average length of the square samples was 13.35±0.01 mm and the average
thickness of the bovine pericardium samples was 0.430±0.004 mm. Experimental raw data
obtained from biaxial testing of the three specimens are shown as Cauchy stress-Green
strain plots in Figure 3.1B. Stress-strain data were fit to the Fung’s strain energy function
in the absence and presence of in-plane shear strains. Material parameters of the bovine
pericardium samples in the absence of in-plane shear strains were shown in Table 3.1. The
parameters were obtained as initial estimate values for the orthotropic Fung model.
Furthermore, material parameters of the bovine pericardium samples considering in-plane
shear strains were shown in Table 3.2. The parameters were obtained as initial estimate
values for the generalized anisotropic Fung model. Material coefficients presented in both
tables satisfied the convexity constraints.
Table 3.1: Dimensions of bovine pericardium specimens and coefficients of Fung strain
energy function fitted to the raw data without in-plane shear strains.
Specimen
1
2
3

Thickness
(mm)
0.433
0.426
0.430

Length
(mm)
13.36
13.34
13.35

w
(kPa)
31.64
85.93
26.78

xTTTT

xUUUU

xTTUU

yU

15.22
46.03
58.61

16.57
30.30
47.05

12.68
25.25
39.21

0.986
0.995
0.992
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Anisotropic
index
0.124
0.127
0.198

Figure 3.7: Flowchart for parameter estimation algorithm, adapted from (Abbasi et al.
2016).
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Figure 3.8: (A) Deformation measures (D1, D2, and D3) in the actual valve and FE
simulation, and (B) Image processing of the three quantitative measures during systole,
adapted from (Abbasi et al. 2016).
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Table 3.2: Material coefficients of Fung strain energy function fitted to the raw data
considering in-plane shear strains.
Specimen
1
2
3

w (kPa)
75.21
96.00
34.22

xTTTT
11.62
28.28
69.75

xUUUU
13.00
27.51
56.49

xTTUU
8.12
22.92
47.07

xTUTU

10.15
79.21
1526.36

xTTTU

-8.19
-20.68
155.02

xUUTU

-11.38
7.15
141.05

yU

0.987
0.996
0.994

3.3.2 In-vitro experimental testing data
The 23mm Carpentier-Edwards Perimount bioprosthesis was tested in the pulse
duplicator to obtain hemodynamic data for testing heart valves. The transvalvular pressure
gradient waveform obtained from the in-vitro test was used as dynamic loading in the FE
simulations (Fig. 3.3). In addition, for the optimization process, bioprosthetic leaflet
motion was analyzed during the systole and the middle-point distance of the three leaflets
with respect to the center of the valve was obtained from image processing (Fig. 3.8A).
Average distance of the three leaflets was obtained during the valve opening. The curve
was filtered in MATLAB and used in the optimization procedure as described previously
(Fig. 3.8B).
3.3.3 Estimated Material Parameters of Bovine Pericardial Leaflets
We used a two-step optimization procedure to determine 3D mechanical properties of
the bioprosthetic leaflets, as well as the Rayleigh damping coefficient introduced to
simulate viscous damping effects of the surrounding fluid. First, equi-biaxial tensile test
of the bovine pericardium specimens was simulated to obtain appropriate initial estimate
values for the out-of-plane material coefficients in both generalized anisotropic and
orthotropic forms of the Fung model. Specimen number 3 was arbitrarily chosen for the
optimization procedure (Fig. 3.1B). Out-of-plane material coefficients of the bovine
pericardium sample were obtained by minimizing the measured and simulated
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displacement vector of the central element in the two orthogonal directions, b and b (Fig.
3.9). The result of material optimization is shown below
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Subsequently in the second step of the optimization procedure, bioprosthetic leaflets
deformation was simulated under the dynamic loading. Inverse parameter estimation was
performed by considering a relatively wide range of initial values in the optimization
framework: 1 ≤

&

≤ 1.6 ×

& (&p&o #q&o#)

and 900 ≤ n ≤ 9000. Material

parameters and viscous damping coefficient of the bioprosthetic leaflets were then
estimated under dynamic loading using PSO method in Isight, by matching the middle
point distance of leaflets in the FE simulation with the experimental measurements as
shown in Fig. 3.10. The estimated material parameters of the bovine pericardial leaflets
based on generalized anisotropic and orthotropic Fung model are listed below
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In addition, the estimated values for @ and n, the viscous damping coefficient, are
presented in Table 3.3.

Figure 3.9: Experimental and optimized (A) circumferential (b) and (B) longitudinal (b)
displacement data, adapted from (Abbasi et al. 2016).
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Table 3.3: Material parameter and viscous damping coefficient for the Fung model.
Fung model
Orthotropic
Anisotropic

w
(Material parameter, kPa)
26.03
24.62


(Viscous damping, 1/s)
2191
2148

The magnitude of viscous damping coefficient controls the opening characteristics of
the aortic valve. Figure 3.11 shows how different values of viscous damping coefficient
would influence on the opening characteristics of bioprosthetic leaflets for the Fungorthotropic model. Considering an identical material coefficient for the leaflets, a higher
value for viscous damping coefficient leads to slower valve opening.

Figure 3.10: Middle point displacement of bioprosthetic leaflet; comparing optimized FE
simulations with the experimental data, adapted from (Abbasi et al. 2016).
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Figure 3.11: Middle point displacement of bioprosthetic leaflet; comparing optimized FE
simulations with the experimental data for different viscous damping coefficients.
3.3.4 Leaflet Stress Distribution of the Carpentier-Edwards Bioprosthesis
Using the optimized material parameters and viscous damping coefficient, the
maximum principal stress distribution of the 23 mm bioprosthesis during a cardiac cycle is
shown in Fig. 3.12. The left-side column depicts the images of valve opening and closing
in the pulse duplicator captured by the high-speed camera. The middle- and right-column
of Fig. 3.12 show FE simulation results based on the estimated values for the orthotropic
and generalized anisotropic Fung models, respectively. During systole, high stress regions
were primarily observed in the fixed boundary edge. The peak stress value at the maximum
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transvalvular pressure gradient, t = 0.215 s, reached to 3.28 and 3.17 MPa in the orthotropic
and generalized anisotropic models, respectively.
In the fully closed position, however, high stress regions were primarily observed in
the commissures. The peak stress value during diastole reached to 2.33 and 1.17 MPa in
the orthotropic and generalized anisotropic models respectively. As shown in Figure 3.12,
in comparison to the experimental data, the anisotropic model simulated the in-vitro leaflet
deformation and shape significantly better than the orthotropic model. Furthermore,
asymmetric leaflet stress patterns were observed in the generalized anisotropic model in
contrast to the orthotropic model where the stress patterns were nearly symmetrical with
respect to the leaflet midlines. The asymmetric leaflet stress pattern was due to the nonfully-symmetric leaflet geometry of the bioprosthesis commonly seen in a handmade
manufacturing process.
3.4 Discussion
3.4.1 Summary
In this study, we presented an approach to obtain material parameters of a generalized
Fung hyperelastic constitutive model used to model bovine pericardial leaflets of a
bioprosthetic valve under dynamic loading conditions. Through an iterative optimization
algorithm, the middle point distance of the leaflets with respect to the center of the valve
in the FE simulations was matched with experimental data obtained from pulse duplicator
measurements. Using inverse parameter estimation process, generalized anisotropic Fung
model parameters were estimated for the bioprosthetic leaflets. Furthermore, the Rayleigh
damping coefficient that was introduced to FE simulations to simulate viscous damping
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Figure 3.12: Comparison of in-vitro leaflet motion with FE simulations throughout a
complete cardiac cycle. (Left column) Experimental data (Middle column) the maximum
principal stress distributions on the bioprosthetic heart valve based on Fung-orthotropic
model (Right column) the maximum principal stress distributions on the bioprosthetic heart
valve based on Fung-anisotropic model, adapted from (Abbasi et al. 2016).
58

effects of surrounding fluid was assessed in the inverse parameter estimation. The
anisotropic model accurately simulated the leaflet shape and deformation during valve
opening and closing, significantly better than the orthotropic model. The highest stress
values were found during the systole in the anisotropic model and the peak stress reached
to 3.17 MPa at the leaflet boundaries. During diastole, however, high stress regions were
primarily observed in the commissures and the peak stress reached to 1.17 MPa. The
maximum leaflet stress at the peak of systole was 63% higher than the maximum principal
stress during diastole.
3.4.2 Impact of Material Models on Leaflet Stress Distribution
During the past few decades, several investigations have been carried out to determine
stress distribution of bioprosthetic leaflets and correlate high stress regions to the regions
of calcification and tissue degeneration. However, the accuracy of the simulations may be
affected using simplified material models for bovine pericardial leaflets, e.g. isotropic or
partially anisotropic material models, or using simplified loading conditions, e.g. quasistatic loading instead of dynamic loading condition. In several computational studies,
material properties of bovine pericardial leaflets have been assumed to be isotropic.
Patterson et al. (Patterson, Howard, and Thornton 1996) investigated the impact of linear
and nonlinear elastic material models on leaflet stress distribution of a bicuspid
bioprosthetic heart valve. The leaflet material properties were isotropic, and a time-varying
pressure differential was applied to the leaflets. Their results showed that the nonlinear
properties of the leaflets have a profound effect on the deformation of the leaflets, and a
maximum stress value of 2 MPa was reported in the commissures at the peak of diastole.
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In addition, Hsu et al. (Hsu et al. 2014) and Kamensky et al. (Kamensky et al. 2015)
developed fluid-structure interaction simulations of a bioprosthetic heart valve immersed
in the lumen of a flexible artery wall under dynamic loading. They considered an isotropic
St. Venant–Kirchhoff material, which assumes a linear stress–strain relationship, for the
leaflets. The peak of maximum in-plane leaflet principal Green strain was 0.483 in the
commissures at the peak of diastole. Recently, Hsu et al. (Hsu et al. 2015) combined an
isotropic Fung model with a neo-Hookean model to capture the exponential stiffening
behavior of soft tissues in the fluid-structure interaction simulations. The peak of maximum
in-plane principal Green strain diminished significantly to 0.319 compare to the St.
Venant–Kirchhoff material used in the previous study.
3.4.3 Out-of-plane Material Properties of Soft Tissue
Biaxial mechanical evaluations of chemically treated bovine pericardium tissues have
shown an anisotropic mechanical behavior (Sacks and Chuong 1998) and (Sacks 2000). To
implement the tissue anisotropy, Sun et al. (Sun, Abad, and Sacks 2005, Sun and Sacks
2005a) incorporated a seven parameter modified Fung model into the ABAQUS through
its user subroutine UMAT to determine leaflet stress distribution of a pericardial
bioprosthesis under quasi-static loading condition. The modified two-dimensional Fung
model only incorporated the in-plane material parameters, as shown in Equation 3.11. The
material parameters were estimated by fitting the model to experimental biaxial data.
Under a quasi-static pressure of 120 mmHg, the highest leaflet stress region was observed
in the vicinity of commissures with a maximum principal stress of 0.92 MPa. Unlike the
quasi-static loading, under dynamic loading, the simplified in-plane Fung material model
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resulted in physiologically unrealistic crimping of the leaflets in the free edge and belly
regions (Kim et al. 2007). To solve the problem, Kim et al. (Kim et al. 2007), (Kim et al.
2008) included a bending moment in the simulation that was calculated based on an
isotropic moment-curvature relationship.

In three-dimensional FE simulations as

presented here, although the out-of-plane normal and shear stresses of shell elements in FE
simulations are zero, the out-of-plane coefficients related to strains of d and d have a
constructive role to impose convexity on the material parameter tensor.
Lack of three-dimensional constitutive models for soft tissue limits the effectiveness
of computational simulations. To compare the results from the optimized properties to the
initial material properties, we would like to discuss about two recent studies in which
arbitrary (random) values were used for the out-of-plane material coefficients. First,
(Jermihov, Jia, Sacks, Gorman, Gorman III, et al. 2011) used the following anisotropic
Fung constitutive model in their computational study. The authors used random small
values for the out-of-plane coefficients in related to strains of E13 and E32 in the Fung
model.
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Second, (Xuan et al. 2017) used the following orthotropic Fung model in ABAQUS to
simulate TAVs. In-plane material coefficients were obtained from biaxial tensile tests and
an arbitrary value of 0.01 was used for the out-of-plane material coefficients.
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To show the importance of characterization of 3D valve-specific mechanical
properties of the leaflets, we used the 9 coefficients of the orthotropic model presented by
(Xuan et al. 2017) in the surgical valve model. As shown in Fig. 3.13, considering
arbitrary small coefficients leads to dynamic instability and wrinkling of the leaflets in FE
model, especially in the opening phase of the valve. Therefore, as discussed in this chapter,
employing optimized material parameters to describe valve-specific mechanical behavior
of the leaflets is essential in computational simulations.
3.4.4 Viscous Damping Coefficient
It has been demonstrated that neglecting viscous damping effects of blood flow in the
finite element simulation of heart valves may cause instability. A wide range of viscous
damping coefficients have been reported in the literature; however, the coefficients were
not fully validated for bioprosthetic heart valves. Kim et al (Kim et al. 2008) considered a
damping constant of 18.9 g/s in their dynamic FE analysis of bioprosthetic heart valves.
However, the damping coefficient was reported in the literature for kinematic modeling of
left ventricular filling (Oommen, Karamanoglu, and Kovács 2002). In a separate study,
Patterson et al. (Patterson, Howard, and Thornton 1996) considered a damping coefficient
of 0.995 in FE simulations of bicuspid bioprostheses in OASYS-LS DYNA3D (LSTC,
Livermore, CA). The value was chosen by inexplicit comparison of leaflet displacements
between FE model and pulse duplicator measurements. In addition, Jermihov et al.
62

Figure 3.13: A sample of dynamic instability in FE model because of using random small
values for the out-of-plane coefficients.
(Jermihov, Jia, Sacks, Gorman, Gorman, et al. 2011) applied a mass-proportional damping
coefficient of 90,000 to the damping matrix to account for blood interactions with the
surface of a congenital bicuspid aortic valve. However, no evidence was provided for
validation the damping coefficient. Recently, Kamensky et al. (Kamensky et al. 2015)
used damping constant per unit area of 80 g/(cm²s) in their bioprosthetic valve simulations
to ensure that the valve opens at a physiologically reasonable time scale. Nevertheless,
again no validation was provided for the damping coefficient. In this study, however, the
viscous damping coefficient was estimated through inverse FE optimization analysis.
3.4.5 Viscoelasticity of Soft Tissue
Biological soft tissues are viscoelastic in nature and their mechanical behavior varies
in response to the rate of deformation. Chemically treated bovine pericardium possess
nonlinear viscoelastic behavior particularly in large deformations (Mavrilas et al. 2005),
(Trowbridge and Crofts 1987) and (Lee et al. 1994). Lee et al. (Lee et al. 1994) used a
servo-hydraulic testing system to evaluate the behavior of chemically treated bovine
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pericardium under loading frequencies at 0.01, 0.1, 1, and 10 Hz. The corresponding strain
rates of the samples in the testing protocol were approximately 0.45, 4.5, 45, and 400 1/s,
respectively. The large deformation stress-strain response was nearly unaffected by loading
frequency during tension, although the stress-strain curve was shifted slightly to the left at
10 Hz. Nevertheless, a significant increase in hysteresis was observed in stress-strain
studies at 10 Hz compared to the lower frequencies.

In our simulation, strain rate

distribution was not uniform throughout the leaflets, and the maximum principle in-plane
strain rate reached to 403 1/s during systole and 114 1/s during the diastole. Hence, by
comparing our results with those of Lee et al. (Lee et al. 1994), the pseudo-elastic Fung
model is a reasonable material model to use to simulate bovine pericardial leaflets.
However, material parameters estimation should be based on the inverse parameter
estimation rather than parameter fitting to experimental biaxial data in order to closely
approximate the viscoelastic behavior of bovine pericardial leaflets during dynamic
loading.
3.4.6 Difficulties of Biaxial Tests
Direct use of material parameters obtained from biaxial tests in numerical simulation
of non-linear anisotropic materials is not appropriate due to technical difficulties in
interpreting biaxial test results (Eilaghi et al. 2009, Nolan and McGarry 2016, Waldman
and Lee 2002). Biaxial testing is commonly used to investigate the mechanics of
anisotropic soft tissues and biomaterials. Test specimens are commonly attached to the
machine actuators using either clamps(Kanyanta and Ivankovic 2010, Waldman and Lee
2002), or rakes/sutures (Humphrey, Strumpf, and Yin 1990, Waldman and Lee 2002).
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Nolan and McGarry (Nolan and McGarry 2016) recently described the fundamental
problem that exist with the calculation of material stress from measured force in standard
biaxial tests using clamps. They showed that localized unmeasured shear forces that occur
at the clamps has significant implications for the calculation of material stress from
simplified force–equilibrium relationships. Furthermore, they demonstrated that the
calculation of a general correction factor for non-linear anisotropic materials that accounts
for material non-linearity and anisotropy is not feasible. Likewise, the difficulties
associated with sutured specimens have been demonstrated previously. Uniformity of the
strain and stress fields is highly sensitive to the number of suture attachment points, the
regularity of their spacing and alignment (Eilaghi et al. 2009, Sacks 2000). Additionally, it
is unclear whether there is full recruitment of collagen fibers throughout the specimen when
sutures are used (Billiar and Sacks 2000, Waldman and Lee 2002). Therefore, a rigorous
inverse FE analysis of biaxial tests should be performed to determine material stress
distribution and calibrate constitutive law material parameters in biaxial tests.
3.4.7 Particle Swarm Optimization (PSO) Algorithm
In this chapter, we used particle swarm optimization (PSO) algorithm, a global
optimization method that is well suited for biomechanical problems(Schutte et al. 2005).
This method has received increasing attention among other optimization algorithms due to
its simplicity and having few algorithm parameters to control the convergence behavior.
In addition, the PSO algorithm is a derivative free method that is less sensitive to objective
functions as well as design variable scaling (Kumar and Minz 2014, Schutte et al. 2005,
Schutte et al. 2004). However, the method possesses an important limitation; the PSO often
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converges more slowly than the other global optimization methods such as genetic
algorithm

and

sequential

quadratic

programming.

Furthermore,

biomechanical

optimization problems are nonlinear and multiple local minima may exist. Therefore, to
obtain a reliable solution, we utilized a two-step global optimization method in this chapter.
The lower and upper bounds of the optimization variables were selected based on the initial
values that were obtained from biaxial stretching tests of bovine pericardium samples.
Therefore, by choosing appropriate initial values, the probability of reaching a global
optimal solution that is physically feasible will be highly increased.
3.4.8 Study Limitations
Although intra-specimen and inter-specimen variations exist in mechanical properties
of bovine pericardium(Sacks, Chuong, and More 1994), variability in the material
properties of the three leaflets was not considered in the simulations to reduce
computational cost. Furthermore, bioprosthetic leaflet motion with respect to the center of
the valve was analyzed and an average distance value was used to match computational
results with the experiment data. However, simultaneous matching of all the three leaflets
with experimental data can be implemented in the optimization procedure. In addition, in
this chapter, we used a two-step global optimization method based on the equibiaxial test
data of bovine pericardium samples and by matching the middle point distance of leaflets
in the FE simulation with the experimental measurements in the pulse duplicator.
Although, a good agreement between the experimental data and FE simulation results was
obtained during valve opening and closing, utilizing other experimental techniques such as
high-speed dynamic strain measurement by advanced 3D photogrammetry would improve
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the uniqueness of the solution. Finally, a Rayleigh damping coefficient was introduced to
the simulations to mimic viscous damping effects of surrounding fluid. However, a more
accurate simulation to consider blood flow shear stresses on the surface of the leaflets may
involve fluid–structure interaction simulation.
3.5 Conclusions
In summary, we presented an approach to obtain material parameters of a pericardial
surgical bioprosthesis based on generalized nonlinear Fung-type constitutive model under
dynamic loading conditions. Using the inverse parameter estimation process, 3D
generalized anisotropic and orthotropic Fung model parameters were estimated for the
bioprosthetic leaflets. Furthermore, the Rayleigh damping coefficient that was introduced
to FE simulations to simulate viscous damping effects of surrounding fluid was assessed.
The generalized anisotropic model accurately simulated the leaflet deformation and
coaptation during valve opening and closing. During systole, high stress regions were
primarily observed at the boundary edge; however, during diastole, high stress regions
were primarily observed in the commissures. The maximum leaflet stress at the peak of
systole was significantly more than the maximum principal stress during diastole. Also, we
presented a step-by-step instruction for employing commercial FE software packages to
non-invasively estimate three-dimensional anisotropic material parameters of soft tissue
and biomedical materials. Commercial FE software packages are widely available and can
be utilized effectively for quantitative description of surgical and transcatheter heart valves
to better understand mechanism of tissue degeneration and improve long-term valve
durability.
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CHAPTER 4: EFFECT OF REDUCED TISSUE THICKNESS IN TAVS
4.1 Introduction
Tissue heart valves in general degenerate through two distinct yet possibly synergistic
processes: 1) calcification and 2) mechanical damage (Schoen 2012). TAV technology uses
the same leaflet tissue as surgical bioprostheses, and therefore it can be postulated that the
failure mechanisms in TAVs are similar to the surgical bioprostheses. Leaflet calcification
is responsible for a significant percentage of surgical bioprosthetic valve degeneration.
Calcification appears to originate mainly within residual connective tissue cells that were
not removed by chemical pretreatment (Schoen 2012). Collagen and elastin fibers can
also work as nucleation sites (Bailey et al. 2003, Schoen and Levy 2005). Furthermore,
it is broadly accepted that mechanical stress accelerates calcification by disrupting tissue
structure. It has been demonstrated that high stress regions correlate with regions of
calcification in stented surgical bioprostheses (Schoen and Levy 1999a).

Besides

calcification, it has been demonstrated that mechanical damage due to fatigue could be
a cause of failure in surgical bioprostheses (Sacks and Schoen 2002b). Due to tissue
fixation procedure, the entire extracellular matrix is vastly bonded which eliminates the
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ability for fibers to slide relative to each other (Sacks et al. 2006). As a result, non-calcific
damage is high likely due to shearing and fiber debonding (Sacks and Schoen 2002b). It
has been demonstrated that high stress regions in stented surgical bioprostheses correlate
with regions of mechanical deterioration (Ferrans et al. 1978b, Sacks and Schoen 2002b).
TAVs are typically implanted using either the transfemoral or non-transfemoral
approaches (left ventricular apex, aorta, axillary, carotid arteries) depending on arterial
iliofemoral suitability. One of the most important design constraints in transfemoral TAVI
is the diameter size of the delivery catheter. The larger diameter of the delivery catheter
may increase the risk of vascular injuries and the occurrence of arterial dissection or
perforation (Borz et al. 2014, Koehler et al. 2015). In the first generation of TAVs studied
in clinical trials, e.g. the Edwards SAPIEN valve evaluated in the PARTNER clinical trial,
22-Fr sheath was used for 23mm valve and 24-Fr sheath was used for 26mm valve in the
transfemoral approach. In the French sizing system, 3 Fr equals 1mm. With technological
advances, newer low-profile systems were designed which were suitable for smaller
catheter delivery systems (e.g., 20/23/26/29mm Edwards SAPEIN XT requires 16-/16-/18/20-Fr, respectively, and 23/26/29/31mm Medtronic CoreValve devices are inserted
through an 18-Fr Cook sheath). Among the new designs recently released, a further
reduction in delivery profile has been observed (e.g., Edwards SAPIEN 3 valve requires
14-/14-/16-Fr for 23/26/29mm valve sizes respectively, and the 23/26/29 mm Medtronic
Evolute R devices require 14-Fr sheath).
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Although low-profile systems reduce the risk of vascular injuries and improve catheter
maneuver for precise placement of TAV devices, the cross-sectional area reduction causes
more constraints in the design of TAV devices. To use smaller cross-sectional areas of
delivery catheters, the valve must be crimped into a small diameter which is less than the
delivery catheter size. It has been shown that crimping may induce structural changes at
the surface and deep layers of TAV leaflets (Alavi, Groves, and Kheradvar 2014a, Abbasi
and Azadani 2015, Khoffi and Heim 2015, Dvir 2016). Therefore, to accommodate TAVs
to the miniaturized catheters and minimize structural damage due to crimping, the
pericardial leaflet thickness of a TAV needs to be reduced to a value which is typically
thinner than a surgical valve leaflet thickness. For example, bovine pericardial leaflet
thickness of a 23mm Carpentier-Edwards PERIMOUNT Magna surgical bioprosthesis is
0.4-0.55 mm, whereas for a similar size TAV the leaflet thickness may be in range of 0.140.18 mm (Li and Sun 2010). Such reductions in the thickness of leaflets may lead to a
decrease in tissue strength to the physiological dynamic loading, and over time can
negatively influence long-term valve durability.
The impact of thickness reduction on leaflet stress and strain distribution under
dynamic physiological loading condition and in the long run on the long-term valve
durability is not known. In the absence of long-term valve durability data, accurate
structural simulations and computational modeling become an integral part of the
evaluation. Therefore, the main objective of this chapter was to use finite element (FE)
simulation to determine the impact of leaflet thickness on TAV leaflet stress and strain
distribution under dynamic loading condition. Leaflet mechanical properties in this study
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were characterized by a three-dimensional anisotropic nonlinear Fung-type constitutive
model to accurately describe tissue mechanical behavior under physiological loading.
4.2 Methods
4.2.1 Constitutive Modeling
Accurate constitutive models are needed for the purpose of characterizing material
behavior of soft tissue in computational modeling. Most native and chemically treated
biological soft tissues are viscoelastic in nature, and often are considered as pseudohyperelastic materials (Fung 2013a). A material can be defined as hyperelastic if there is a
stored (strain) energy function Ψ which is exclusively a function of the deformation
gradient tensor. Fung strain-energy function has become a widespread strain energy
function to describe nonlinear mechanical behavior of numerous biological soft tissues
(Fung, Fronek, and Patitucci 1979). A generalized Fung strain-energy function in threedimensional space is in the form of
@
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Details of the generalized Fung strain-energy function have been previously described
in chapter 3. The number of components of F that have to be determined is similar to the
elasticity tensor, namely 21 independent components for a three-dimensional generalized
anisotropic Fung strain-energy function as shown below.
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4.2.2 Heart Valve Tissue Mechanical Properties
The majority of experimental testing used to estimate mechanical properties of soft
tissue such as in-plane biaxial testing cannot capture the out-of-plane displacements
required to determine three-dimensional anisotropic mechanical properties of tissue
(Holzapfel and Ogden 2008). We have previously shown the use of inverse FE analysis to
determine three-dimensional anisotropic mechanical properties of bovine pericardial
leaflets of a surgical bioprosthesis under dynamic physiological loading condition (Abbasi
et al. 2016). Briefly, a two-step global optimization technique was utilized by first
simulating the equibiaxial test data of bovine pericardium samples to obtain initial estimate
values for the out-of-plane material coefficients, and second by matching the middle point
distance of bioprosthetic valve leaflets in the FE simulation with experimental
measurements of bioprosthetic leaflet motion in a custom-built pulse duplicator. A heart
rate of 70beat/min mean aortic pressure of 100mm-Hg, and cardiac outputs (COs) of 5.0,
3.5, and 2.0L/min were used as the pulse duplicator input parameters.
Using the inverse parameter estimation process previously described in chapter 3,
three-dimensional generalized anisotropic Fung model parameters were estimated for the
bioprosthetic leaflets (Equation 4.3). Furthermore, the Rayleigh damping coefficient (n),
that was introduced to FE simulations to simulate viscous damping effects of surrounding
fluid, and @, were determined, i.e. n = 2,148 (1/s) and @ = 24.62 KPa for CO=5 L/min. In
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addition, the α was determined as 1007 and 816 (1/s) for cardiac outputs of 3.5 L/min and
2 L/min, respectively. The generalized anisotropic Fung model accurately simulated the
leaflet deformation and coaptation during valve opening and closing (Abbasi et al. 2016).
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Using the obtained material properties, a good agreement between the experimental data
and FE simulation results was obtained during valve opening and closing in CO=5 L/min
(Fig. 4.1A). The simulation results were further validated for CO of 3.5 and 2.0 L/min and
a good agreement was observed between leaflet displacement obtained from the
experimental tests and FE simulations during valve opening and closing (Fig. 4.1B).
Details of Rayleigh damping coefficient impact on heart valve tissues have been previously
described (Abbasi and Azadani 2015, Abbasi et al. 2016). There are few papers in literature
in which generalized anisotropic Fung model was used to characterize the threedimensional anisotropic bovine pericardium mechanical properties in ABAQUS software
(Jermihov, Jia, Sacks, Gorman, Gorman III, et al. 2011, Xuan et al. 2017). They considered
a bunch of arbitrary or very small values for material coefficients which could not be found
by biaxial stretching testing.
4.2.3 Finite Element Modeling
In this study, the three-dimensional geometry of the TAV was selected based on the
Edwards SAPIEN XT valve design. Since the TAV leaflet geometry is similar to that of
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Figure 4.1: (A) Comparison of in-vitro leaflet motion with FE simulations throughout a
complete cardiac cycle for cardiac output 5 L/min. (B) Leaflets displacement during systole
for cardiac outputs of 3.5 and 2.0L/min. A good agreement was observed between the
experimental data and FE simulations, adapted from (Abbasi and Azadani 2017).
the 23mm Carpentier-Edwards PERIMOUNT Magna bioprosthetic aortic valve, we
obtained the leaflet geometry by three- dimensional scanning of the surgical valve.
Details of the Surface reconstruction of the leaflets, making the mesh pattern and FE
models have been previously described in chapters 2 and 3.
Due to the relatively high stent radial force, leaflets were only modeled in the
simulations and the stent was considered to be rigid. The leaflet thickness was assumed
uniform and constant throughout the leaflet. To determine the impact of the thickness
reduction on leaflet stress and strain distribution, five different thickness values were
considered in the FE simulations, namely 0.18, 0.2, 0.3, 0.4, and 0.5mm. A transvalvular
pressure gradient waveform obtained from the in-vitro test in the pulse duplicator was
applied to the leaflets under dynamic loading (Fig. 4.2). Details of the in-vitro
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Figure 4.2: Bioprosthetic pressure and flow rate waveforms, adapted from (Abbasi and
Azadani 2017).
experimental testing procedure have been previously described in chapters 2 and 3. In the
dynamic analysis, density of 1,100 kg/m³ was used for the leaflet tissue. Moreover, a
Rayleigh damping coefficient was considered in the simulations to mimic viscous damping
effects of surrounding fluid. In post-processing, the surface of the leaflets was divided into
four main zones as shown in Fig. 4.3 to evaluate stress and strain regions: zone 1:
commissures; zone 2: free edge; zone 3: fixed edge; and zone 4: belly region.
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Figure 4.3: Surface of the leaflets were divided into four main zones for post-processing,
adapted from (Abbasi and Azadani 2017).
4.3 Results
4.3.1 Leaflet Stress Distribution
The maximum principal stress distribution of the TAV leaflets at the peak of systole
and at the peak of diastole (i.e., the largest pressure gradient across the valve) is shown in
Figure 4.4 for leaflet thicknesses ranging from 0.18mm to 0.5mm. At the peak of systole,
high stress regions were mainly observed at the leaflet fixed edge (zone 3). The maximum
principal stress increased significantly with decreasing the leaflet thickness. During
diastole, however, high stress regions were primarily observed at the commissures (zone
1). The maximum principal stress at the commissures of the leaflets increased as the leaflet
thickness decreased. Furthermore, the maximum principal stress in the belly of the leaflets
increased in the diastole with decreasing the leaflet thickness. Localized high stress regions
were observed in the belly region as the leaflet thickness decreased due to bending of the
tissue at the base of the leaflet contact area (Figure 4.4).
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Figure 4.4: 1st principal stress of TAV leaflets at the peak of systole and at the peak of
diastole for various leaflet thicknesses, adapted from (Abbasi and Azadani 2017).
Figure 4.5 shows the peak of maximum principal stress in the leaflets versus thickness
at the peak of systole and diastole. Simulation results showed that the peak maximum
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principal stress was increased at the peak of systole in an exponential manner from
3.17MPa to 9.17MPa after reducing the thickness from 0.5mm to 0.18mm. Furthermore,
the peak maximum principal stress at the peak of diastole was increased from 1.17MPa to
7.11MPa in an exponential manner after reducing the thickness from 0.5mm to 0.18mm.
In addition, stress history of the four zones was obtained during one cardiac cycle for all
the thicknesses. As shown in Fig. 4.6, the local maximum stress history in all the zones
was changing considerably during one cardiac cycle. The stress variation is important to
be considered in fatigue assessment of the leaflets. At the peak of systole, a local maximum
stress was observed in the stress history at the commissures (zone 1), the fixed edge (zone
3), and the belly region (zone 4). During diastole, an elevated stress level was observed in
all the regions of the leaflets. The maximum principal stress of the leaflets increased as
the leaflet thickness decreased.

Figure 4.5: Maximum principal stress of TAV leaflets versus leaflet tissue thickness,
adapted from (Abbasi and Azadani 2017).
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Figure 4.6: (A) The peak of 1st principal stress of TAV leaflets versus time in zone-1
(commissures). (B) The peak of 1st principal stress of TAV leaflets versus time in zone-2
(free edge). (C) The peak of 1st principal stress of TAV leaflets versus time in zone-3 (fixed
edge). (D) The peak of 1st principal stress of TAV leaflets versus time in zone-4 (belly
region), adapted from (Abbasi and Azadani 2017).
4.3.2 Leaflet Strain Distribution
Figures 4.7 and 4.8 show the distribution of normal and shear logarithmic strain (LE)
components ( ,  ,  , dd ) within the leaflets of the TAV at the peak of systole
and at the peak of diastole. The 1-, 2-, and 3-directions were aligned with circumferential,
radial, and normal directions of the leaflets, respectively. As presented in Figure 4.7, TAV
leaflet strain distributions at the peak of systole were dependent on the thickness of the
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TAV leaflets. After employing thinner thicknesses in the FE simulation, the absolute value
of in-plane and out-of-plane normal strain components were increased. The magnitude of
shear strain ( ) was comparable to the normal in-plane strain valves at the peak of

systole in all the simulations. Moreover, considerable negative normal strain values (dd )

were observed at the leaflet fixed edge at the peak of systole due to deformation and tissue
incompressibility. Similar to the peak of systole, at the peak of diastole, the absolute value
of in-plane and out-of-plane strain components of the leaflets increased as the leaflet
thickness decreased (Figure 4.8).
A considerable change in thickness (dd ) and shear strain ( ) was observed in the
leaflets, indicating the importance of using the three-dimensional anisotropic constitutive
model in the simulations. In contrast to stress distribution which increased significantly as
the thickness decreased, strain distribution did not change considerably as the thickness
decreased due to the non-linear stress-strain characteristics of the soft tissue.
4.4 Discussion
4.4.1 Summary
In this chapter, we examined the impact of leaflet thickness on TAV leaflet stress and
strain distribution under dynamic loading conditions. A generalized anisotropic Fung
hyperelastic constitutive model was used to model bovine pericardial leaflets of a 23mm
TAV. Through dynamic FE simulations, we found that the highest stress values were
found during the systole in the leaflet fixed edge. On the other hand, at the peak of diastole,
high stress regions were mainly observed in the commissures. The peak stress was
increased by 178% and 507% within the leaflets after reducing the thickness of 0.5mm to
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0.18mm at the peak of systole and diastole, respectively.

In contrast to the stress

distribution, the changes in the logarithmic strain components were not as significant as
the stress distribution due to the non-linear stress-strain characteristics of the leaflets. All
of the strain components were increased by less than 25% after reducing the thickness
from0.5mm to 0.18mm, except for the in-plane shear strain component which was
increased by 67%.

Figure 4.7. Distribution of normal and shear logarithmic strain components of TAV leaflets
at the peak of systole for various leaflet thicknesses, LE11: logarithmic strain in
circumferential direction, LE22: logarithmic strain in radial direction, LE12: shear
logarithmic strain, LE33: logarithmic strain in normal direction, adapted from (Abbasi and
Azadani 2017).
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Figure 4.8: Distribution of normal and shear logarithmic strain components of TAV leaflets
at the peak of diastole for various leaflet thicknesses, LE11: logarithmic strain in
circumferential direction, LE22: logarithmic strain in radial direction, LE12: shear
logarithmic strain, LE33: logarithmic strain in normal direction, adapted from (Abbasi and
Azadani 2017).
4.4.2 Durability in TAVs
TAVR is uniquely different from surgical aortic valve replacement (SAVR) using
bioprosthetic valves. TAVs are not sutured into place like surgical bioprostheses but
crimped into delivery sheaths and re-expanded in the aortic annulus. In addition, TAV
design is fundamentally different from surgical valves with thinner leaflets to fit within
82

delivery catheters. Recent randomized clinical trials have demonstrated TAVI was similar
to SAVR in intermediate-risk patients with respect to the primary end point of death and
disabling stroke, and superiority of transfemoral TAVI over SAVR (Leon et al. 2016b).
With the data on intermediate-risk patients and the notion clinical trial showing
equivalence of TAVI with SAVR in low-risk patients (Thyregod et al. 2015), TAVI with
its percutaneous approach may dominate the SAVR market for the treatment patients with
severe aortic stenosis. However, clinical data have durability demonstrated only to 10
years in few patients thus far, since most clinical trials were in patients >80 years old(Arora
et al. 2017).

In contrast, surgical bioprosthetic valves such as Carpentier-Edwards

PERIMOUNT Magna Ease demonstrated excellent durability and hydrodynamic
performance after an equivalent of 25 years in in-vitro accelerated durability tests (Raghav
et al. 2016a).
4.4.3 Effect of Reduced Tissue Thickness on Leaflets Stress Distribution
Based on our dynamic FE simulations, higher stresses and strains have been witnessed
within TAV leaflets due to using thinner leaflets compared to surgical bioprostheses.
Therefore, TAVs can be expected to have reduced long-term durability compared to
surgical valves. Previously, Li and Sun (Li and Sun 2010) performed a static simulation
of a 23mm TAV under a static pressure-only loading condition of 120 mm-Hg. Bovine
and porcine pericardium tissues were obtained from local abattoirs and were chemically
treated with 0.625% glutaraldehyde. Mechanical properties of the tissue were obtained
using a biaxial mechanical testing system. Subsequently, a two-dimensional Fung-type
elastic model was used for constitutive modeling of the bovine and porcine pericardium
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samples. The static FE simulation results showed that the highest stress regions on the
valve leaflets were reported in the vicinity of the leaflet commissures. The peak of
maximum principal stresses was reduced with the increase of leaflet tissue thickness by
36% and 59%, from the mean thickness of bovine pericardium samples (0.24 mm) and
porcine (0.18 mm) pericardium samples to 0.35 mm, respectively. The peak of maximum
principal stresses value for bovine and porcine pericardium samples with a thickness of
0.35 mm reached to 0.59 and 0.64 MPa, respectively. In addition, for the mean thickness
of bovine pericardium samples (0.24 mm) and porcine (0.18 mm) pericardium samples, the
peak of maximum principal stresses was 0.92 and 1.57 MPa. In this study, we examined
the impact of leaflet thickness on TAV leaflet stress and strain distribution under dynamic
loading conditions using three-dimensional anisotropic Fung model. Under dynamic
loading, at the peak of systole, the highest stress region on the leaflets was found in the
leaflet fixed boundary edge. During diastole, however, high stress regions were mainly
observed at the commissures. Stress history diagrams of the leaflets were obtained for
various thicknesses, necessary to be considered in fatigue assessment of the leaflets.
Although several constitutive models have been used to characterize mechanical
properties of biological soft tissues under physiological loading conditions, only a few
models were proposed as failure/damage models of soft tissue. In a pioneer work, Simo
(Simo 1987) developed a fully three-dimensional finite-strain viscoelastic damage model
based on irreversible thermodynamics with internal variables. Over the past decade, a few
soft tissue damage models utilized the concept of Simo’s model as the basis for their
models (Rodríguez et al. 2006, Alastrué et al. 2007, Calvo et al. 2007, Peña 2011, Li and
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Robertson 2009). In the models, soft tissue damage was dependent only upon the strain
history and not on the number of loading cycles. Recently, Martin and Sun (Martin and
Sun 2012) have proposed a phenomenological damage model to describe tissue fatigue
damage of tissue heart valves due to strain history and number of loading cycles. Based
on the fatigue model and static FE simulations, Martin and Sun reported that durability of
TAVs may be considerably reduced under identical loading conditions compared to
surgical valves to about 7.8 years (Martin and Sun 2015).
4.4.4 Study Limitations
In this chapter, leaflet mechanical properties were estimated through inverse FE
optimization analysis of a 23mm Carpentier-Edwards surgical bioprosthesis with an
average thickness of 0.513 mm (Abbasi et al. 2016). Alteration in mechanical properties of
bovine pericardium leaflets may exist for various thicknesses. The thinner tissue specimens
might be more compliant. Although the absence of thickness-specific material properties
of the leaflets was considered as a limitation of the present work, considering reduced
mechanical property values, even higher stress values is expected to be obtained in leaflets
with reduced thickness. Therefore, the results of this study are claimed to be valid and not
affected by the simplification. Finally, we assumed the same material properties in all three
leaflets in order to reduce computational cost.

However, intra-specimen and inter-

specimen variations may exist in material properties of bovine pericardium as highlighted
by Sacks et al. (Sacks, Chuong, and More 1994).
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4.5 Conclusions
In summary, FE simulations were developed to study the impact of thickness reduction
on leaflet stress and strain distributions. We found that TAV leaflet stress and strain
distributions were dependent on the tissue thickness of the TAVs. By reducing TAV leaflet
thickness to minimize the cross-sectional area of crimped TAVs, higher leaflet stress
distribution is expected. Increased mechanical stress on TAV leaflets due to thickness
reduction may lead to diminished long-term valve durability. As a result, by using thinner
leaflets, TAV durability may not match with that of surgical bioprostheses.
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CHAPTER 5: STRAIN MAPPING OF BIOPROSTHESES USING DIGITAL IMAGE
CORRELATION
5.1 Introduction
To assess longevity of the currently available TAVs and develop the next generation
of heart valve prostheses, in-depth comparison and assessment of strain and stress of the
leaflets is essential. Numerous computational models have been developed to determine
stress and strain distribution of the bioprosthetic heart valve leaflets under physiological
loading conditions (Abbasi et al. 2016, Gunning, Vaughan, and McNamara 2014, Hsu et
al. 2015, Martin and Sun 2015). In the computational simulations, considering robust and
accurate constitutive models for the leaflets is of the utmost importance (Humphrey 2003,
Holzapfel and Ogden 2009). As a result, experimental validation of the computational
models should be an indispensable step to confirm the accuracy and reliability of the
simulations (Abbasi et al. 2016). Due to the limited temporal and spatial resolution of the
currently available imaging modalities in real-world in vivo clinical cases as applied to
bioprosthetic heart valves, in-vitro experimental testing of the bioprostheses provides a
viable alternative to characterize soft tissue mechanical properties and validate the
computational simulations. High-resolution optical measurements can be regarded as an
appropriate non-invasive in vitro measurement technique to assess the deformation of the
leaflets and determine the strain field. A suitable and accurate optical measurement
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technique is three-dimensional digital image correlation (DIC) technique which becomes
more readily available and more widely used in experimental mechanics (Chu, Ranson,
and Sutton 1985, Palanca, Brugo, and Cristofolini 2015, Rogge et al. 2013, Luyckx et al.
2014, Sun, Abad, and Sacks 2005). The DIC technique is particularly suited for
determination of TAV leaflet deformation due to its high temporal and spatial resolution
(Heide-Jørgensen et al. 2016).
The goal of this chapter was to perform a side-by-side comparison of leaflet
displacement and strain fields of three commonly used bioprosthetic heart valves: (i)
Carpentier-Edwards PERIMOUNT Magna surgical bioprosthesis, (ii) Medtronic
CoreValve, and (iii) Edwards SAPIEN 3 using a high-resolution DIC system. The obtained
results can be used to characterize the anisotropic material behavior of the leaflets and
validate computational models of the commercially available bioprosthetic valves.
5.2 Materials and Methods
5.2.1 Bioprosthetic Heart Valves
In this chapter, three different bioprosthetic heart valves with comparable size were
investigated (Fig. 5.1). The first bioprosthetic valve was a 25-mm Carpentier-Edwards
(CE) PERIMOUNT Magna aortic heart valve (Edwards Lifesciences, CA, USA). The
surgical bioprosthetic valve consists of bovine pericardium leaflets mounted on an
Elgiloy frame.
The internal diameter of the frame is 24 mm. The second bioprosthesis was a selfexpanding 26-mm Medtronic CoreValve (Medtronic, Minneapolis, MN, USA),
constructed from porcine pericardial leaflets mounted on a self-expanding Nitinol stent.
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The third bioprosthetic valve examined in this study was a 26-mm Edwards SAPIEN 3
(Edwards Lifesciences, Irvine, CA, USA). The TAV is made from bovine pericardial
leaflets mounted on a balloon-expandable cobalt-chromium stent. The thicknesses of the
bioprosthetic heart valve leaflets were measured using a Mitutoyo Digital caliper. The
average thickness of the leaflets of the PERIMOUNT Magna, Medtronic CoreValve, and
Edwards SAPIEN 3 bioprostheses was 0.56 mm, 0.43 mm, and 0.32 mm, respectively.
5.2.2 Digital Image Correlation System
For DIC measurements, graphite (synthetic powder, < 20µm, Sigma-Aldrich, St.
Louis, MO) was applied to the top side of the leaflets to achieve a speckled pattern (Fig.
5.2). Graphite was used due to its negligible effect on the mechanical properties of soft
tissue as compared to ink dyes, verified by planar biaxial testing of bovine pericardial
patch. To create a suitable stochastic pattern, graphite was applied multiple times to the top
side of the leaflets. Subsequently, the valves were stored in normal saline solution at the

Figure 5.1: (Left) 25-mm surgical Carpentier-Edwards PERIMOUNT Magna Pericardial
bioprosthetic aortic valve. (Center) 26-mm self-expanding Medtronic CoreValve. (Right)
26-mm ballooned expandable Edward SAPIEN 3 transcatheter heart valve, adapted from
(Abbasi et al. 2018a).
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room temperature prior to the DIC measurements. All the DIC measurements were
conducted in an in-vitro test setup comprised of an optically clear acrylic chamber,
peristaltic pump, pressure transducer, and data acquisition system (Fig.5.3). The valves
were mounted inside the chamber using a silicone washer on a custom-made fixture
fabricated by a U-Print SE Plus 3D printer (Stratasys Ltd., MN, USA). A Masterflex
peristaltic pump (Cole Parmer Instrument Co., Chicago, IL, USA) was used to fill the valve
housing and apply uniform pressure within the chamber. The bioprosthetic valves were
submerged fully in the chamber and care was taken to make sure no air bubbles remained
in the chamber. Pressure in the chamber was measured continuously by a pressure
transducer (Deltran, Utah Medical Products Inc., UT, USA), which was calibrated prior to
the tests using a Delta-Cal Pressure Transducer (Utah Medical Products Inc., UT, USA).
The chamber pressure was monitored by StatysTM software (BDC Laboratories, Wheat
Ridge, CO, USA) and recorded simultaneously by a data acquisition system (NI SCC-68,
National instruments, TX, USA).
DIC imaging was performed using a GOM-ARAMIS stereovision system (GOMOptical Measuring Techniques, Braunschweig, Germany) distributed by Trilion Quality
Systems in the USA). The system consists of two high-speed cameras with a resolution of
5 megapixels (2448 x 2050 pixels) equipped with 50 mm focal length Titanar lenses (Fig.
5.4). To achieve a high contrast in the speckled pattern, the valve surface was lightened
by two pattern, the valve surface was lightened by two integrated LED lights (Schneider
Optische Werke, GmbH, Bad Kreuznach, Germany). The DIC system was calibrated prior
to the tests to accommodate a measuring volume of 80 × 80 × 65 mm. The calibration
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Figure 5.2: Example of speckled pattern and facets points that were used for post
processing of the experimental data. (A) 25-mm surgical Carpentier-Edwards
PERIMOUNT, (B) 26-mm Medtronic CoreValve, and (C) 26-mm Edward SAPIEN 3,
adapted from (Abbasi et al. 2018a).
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Figure 5.3: A schematic overview of the in-vitro DIC-based experiments consisting of (1)
homemade valve housing, (2) water pool, (3) Masterflex peristaltic pump, (4) two highspeed cameras with two integrated LED light sources, (5) DIC system, (6) the pressure
transducer, and (7) the data acquisition system, adapted from (Abbasi et al. 2018a).
procedure for the cameras was done based on the user manual of ARAMIS. The angle
between the two cameras was ~25° and the distance between two cameras was 216 mm.
Both cameras were placed at the measuring distance of 575 mm from the valve housing.
For each one of the bioprostheses, DIC measurement was conducted both from top and
side views in separate experiments.
A change in the pump speed resulted a corresponding change in the pressure within
the testing chamber, and the chamber pressure was simultaneously monitored by StatysTM
software. Prior to data collection, 10 preconditioning cycles were applied to the leaflets at
a rate of 0.5 Hz. In each cycle, the pressure inside the chamber was cyclically changed
from 20 mmHg to 30 mmHg. After preconditioning, the pump speed was increased from
120 rpm to 180, 300, and 480 rpm at a fixed rate of 1 Hz, corresponding to low, medium,
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Figure 5.4: A photograph of the in-vitro experimental setup, adapted from (Abbasi et al.
2018a).
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high loading frequencies, respectively. Separate experiments were conducted for each
pump setting. Loading was followed by an unloading stage and the pump speed was
reduced to 120 rpm at a fixed rate of 1Hz. Simultaneously with pressure alteration, image
acquisition was triggered in the DIC system and image series were collected and stored
using the ARAMIS DIC software (ARAMIS v2016, GOM, Braunschweig, Germany) at a
frame rate of 10 frames per second. Following image acquisition, image processing was
performed using the ARAMIS DIC software by discretizing all the images to a grid of
square subsets of pixels called facet point (FP). A few sample FPs are shown in Fig. 5.2,
e.g., FP 1 and FP 2 on the belly region and FP 3-6 parallel to the leaflet free edge. An
identical facet size (19 pixels) was considered for all the three valves. Leaflet deformation
was determined by tracking the movement of all the facet points. 3D surface contours of
the displacement map and corresponding strain values were determined with respect to a
reference configuration, i.e. chamber pressure of 30-mmHg.
5.3 Results
5.3.1 Pressure Curves
The obtained pressure curves in the in-vitro test setup for the three pump settings, i.e.
180, 300, 480 rpm, are presented in Fig. 5.5. Three distinct pressure curves were obtained
for the three pump settings was expected. Pressure build-up magnitude and time were
similar for the two TAV devices. However, the pressure build-up magnitude and time was
higher and shorter, respectively, in the CE PERIMOUNT Magna surgical bioprosthesis
compare to the two TAVs particularly in 300 and 480 rpm pump settings. For example, at
pump speed of 480 rpm, the pressure build-up magnitude in the CE PERIMOUNT Magna
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Figure 5.5: Pressure curves acquired from the in-vitro experimental setup during loading
and unloading. (Top) 25-mm surgical Carpentier-Edwards PERIMOUNT Magna, (Middle)
26-mm Medtronic CoreValve, and (Bottom) 26-mm Edward SAPIEN 3, adapted from
(Abbasi et al. 2018a).
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surgical bioprosthesis was 44% and 34% higher than the Medtronic CoreValve and
Edwards SAPIEN 3, respectively. At the same time, the CE PERIMOUNT Magna
bioprosthesis reached to the peak pressure 30% and 19% faster than the CoreValve and
SAPIEN 3, respectively. The main reason behind the difference in pressure curves between
the SAV and the two TAVs was the perfectly closed leaflet geometry of the surgical
bioprostheses at zero-loading condition which prohibits any central leakage upon small
pressure applied to the leaflets of the surgical valve.
5.3.2 Displacement Map
The representative displacement contour plots of the bioprosthetic valve leaflets at
pressures of 40, 80, and 120 mmHg are presented in Fig. 5.6. At 120 mmHg pressure, high
displacement regions were observed at the leaflet belly region for the PERIMOUNT
Magna, CoreValve, and SAPIEN 3 bioprostheses. The maximum leaflet displacement
value for the PERIMOUNT Magna, Medtronic CoreValve, and Edwards SAPIEN 3 with
respect to the reference configuration (chamber pressure of 30-mmHg) was 1.80, 0.80, and
0.92 mm, respectively. Unlike the CE PERIMOUNT Magna and SAPIEN 3 bioprostheses,
the displacement contour for the CoreValve was not symmetric due to a subtle asymmetry
in the geometry after leaflet cooptation under loading. In addition, the frame of the surgical
bioprosthesis was found to be flexible under the loading conditions (Fig. 5.7). For instance,
the maximum displacement of the frame reached to 0.63 mm at 120 mmHg pressure.
However, the stent of CoreValve and SAPIEN 3 was found to be inelastic and rigid under
similar loading conditions. It was observed that maximum displacement of the CoreValve
and SAPIEN 3 stents at the commissures was 0.04 and 0.06 mm at 120 mmHg pressure,
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Figure 5.6: Displacement contour plots of the leaflets of bioprostheses valve leaflets at
pressures of 40, 80, and 120 mmHg at the pump speed of 480 rpm, adapted from (Abbasi
et al. 2018a).
respectively. Overall, the results of the experiments show that the stent deformation of
TAVs was negligible compared to the surgical bioprosthesis. To evaluate the viscoelastic
behavior of the pericardial leaflets, experimental pressure–displacement curves were
obtained at the three pump speeds for the high displacement region,which was the belly
region of the leaflets. Figure 5.8 shows the pressure–displacement curves of FP 1, as
marked in Fig. 5.2, on the belly region of the three bioprosthetic valves. The FP 1
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Figure 5.7: Pressure–displacement curves of the left marker mounted on the PERIMOUNT
Magna frame close to the commissure at the pump speed of 480 rpm, adapted from (Abbasi
et al. 2018a).
coordinates with respect to the commissures at the reference pressure configuration are
given in the supplementary material. It was observed that the loading and unloading curves
were of different shape. Moreover, the large deformation response was not fundamentally
affected by the loading rate.
5.3.3 Strain Map
Strain can be calculated and determined from the obtained displacement field. The
contour maps of the major (principal) in-plane Green strain of the three bioprostheses at
pressure of 120 mmHg and pump speed of 480 rpm were depicted in Fig. 5.9. The contour
maps were obtained from top view DIC measurements. Table 5.1 shows the major
(principal) in-plane Green strain values in the belly region of the bioprosthetic valve
leaflets in vicinity of FP1 at different pressure levels. It was observed that the maximum
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Figure 5.8: Experimental pressure–displacement curves of FP 1 (see Fig 5.2) on the belly
region of (Top) 25-mm surgical Carpentier-Edwards PERIMOUNT Magna, (Middle) 26mm Medtronic CoreValve, and (Bottom) 26-mm Edward SAPIEN 3 bioprosthesis, adapted
from (Abbasi et al. 2018a).
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Figure 5.9: The Green major (principal) in-plane strain contour plots of the bioprosthetic
valve leaflets at pressure of 120 mmHg at the pump speed of 480 rpm, adapted from
(Abbasi et al. 2018a).
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Table 5.1: Major (principal) in-plane Green strain in the belly region of the bioprosthetic
valve leaflets in vicinity of FP1 of the bioprosthetic valve leaflets at different pressures
(pump speed: 480 rpm).
Pressure

40 mmHg

60 mmHg

80 mmHg

100 mmHg

120 mmHg

PERIMOUNT Magna

1.6%

2.5%

3.3%

3.6%

4.0%

CoreValve

1.6%

2.2%

3.2%

4.0 %

4.6%

SAPIEN 3

1.6%

2.1%

2.7%

3.1%

3.3%

in-plane principal strain was increased as the chamber pressure was raised. In addition,
Table 5.2 shows the principal Green strain values at different pressure settings for a region
close to the commissures as shown by red markers in Fig. 5.10. For PERIMOUNT Magna
and Edwards SAPIEN 3, the principal strain values were higher in the region close to the
commissures than the belly region. For Medtronic CoreValve, however, the strain values
were lower in the commissure region than the belly region. Nevertheless, the maximum
strain value on CoreValve leaflets were found below the commissure region close to the
fixed boundary edge, as marked by a blue marker in Fig 5.10. The principal strain values
for the region below the commissure and close to the fixed boundary edge were 1.5%,
2.3%, 3.1%, 4.6 %, and 5.3%, at a pressure of 40, 60, 80, 100, and 120 mmHg, respectively.

Table 5.2: Major (principal) in-plane Green strain at different pressure settings for a region
close to the commissure shown by red markers in Fig 5.10 (pump speed: 480 rpm).
Pressure

40 mmHg

60 mmHg

80 mmHg

100 mmHg

120 mmHg

PERIMOUNT Magna

2.1%

3.4%

4.3%

4.5%

5.8%

CoreValve

1.1%

1.8%

2.3%

3.0 %

3.2%

SAPIEN 3

1.1%

2.4%

4.1%

4.8%

5.9%
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Figure 5.10: Location of facet points close to the commissure region in the three
bioprosthetic heart valves identified by red cross markers. The maximum strain value on
CoreValve leaflets were found below the commissure region close to the fixed boundary
edge as marked by a blue circle marker, adapted from (Abbasi et al. 2018a).
5.4 Discussion
5.4.1 Summary
In this chapter, we presented an experimental framework to determine leaflet
displacement field of CE PERIMOUNT Magna surgical bioprosthesis, Medtronic
CoreValve, and Edwards SAPIEN 3 using 3D DIC measurements. A time-dependent
uniform pressure was applied to the leaflets of the bioprosthetic valves mounted in a
custom-made testing system. Through the in-vitro experiments, we found that in all the
three bioprosthetic heart valves the maximum leaflet displacement was generally in the
upper part of the belly region. However, higher displacement values were observed in the
CE PERIMOUNT Magna than CoreValve and SAPIEN 3 bioprostheses. In addition, the
frame of the surgical bioprosthesis was found to be markedly flexible under the loading
conditions. However, the stent of CoreValve and SAPIEN 3 was found to be rigid under
the same loading condition. Frame flexibility and higher leaflet displacement magnitude of
the SAV as compared to those for the two TAVs can potentially alter leaflet stress
distribution and may be related to the altered long-term durability among different
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bioprostheses. The acquired experimental data can be used to characterize the 3D
anisotropic mechanical properties of the leaflets and validate computational models of the
commercially available bioprosthetic heart valves. Moreover, the experimental
observations underline the fact that there are significant differences between geometry and
deformation characteristics of TAVs and SAVs, which may lead to altered long term
durability of the bioprostheses.
5.4.2 Long-term durability of SAVs
Long-term durability assessment of tissue heart valves is crucial to choose the right
prosthetic heart valve for aortic valve replacement. Particularly, to expand TAVR into lowrisk younger patients, TAV durability must match with that of surgical bioprostheses.
Although there is no unified definition of structural valve degeneration, the rate of
structural valve degeneration in surgical bioprostheses is known to be less than 15% at 10
years (Rodriguez-Gabella et al. 2017). Forcillo and colleagues (Forcillo et al. 2013) in a
retrospective cohort study studied 2,405 patients with a mean age of 71 ± 9 years old who
underwent aortic valve replacement with Carpentier-Edwards surgical pericardial
bioprostheses. They found that the overall freedom rate of valve reoperation for valve
dysfunction averaged 96% ± 1% and 67% ± 4% at 10 and 20 years, respectively. It is also
well known that the rate of reoperation for surgical valve dysfunction is strongly affected
by age. As an example, Bourguignon and colleagues (Bourguignon, El Khoury, et al. 2015)
demonstrated that the freedom from reoperation rates attributable to structural valve
deterioration in patients aged 60 or younger who received

Carpentier-Edwards

PERIMOUNT aortic valve were 88.3% ± 2.4% and 38.1% ± 5.6% at 10 and 20 years,
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respectively. Besides clinical studies, an in-vitro experiment was recently conducted in
accordance with ISO 5840:2005 heart valve standard to assess the long-term durability of
the CE PERIMOUNT Magna Ease Bioprostheses (Raghav et al. 2016b). In the study, the
long-term mechanical durability and hydrodynamic performance of the valve were
evaluated through 1 billion cycles (equivalent to 25 years) considering mechanical wear
and tear in the absence of calcification. The results showed that the Carpentier-Edwards
Magna Ease valves are able withstand the mechanical environment of aortic valves for up
to 25 years and perhaps even longer.
5.4.3 Long-term durability of TAVs
In contrary to SAVs, there is a paucity of clinical data regarding long-term durability
of TAVs. Recently, Dvir and colleagues (Dvir et al. 2016) conducted a study to evaluate
long-term durability of TAVs including Cribier-Edwards, Edwards SAPIEN, and Edwards
SAPIEN XT for 378 patients followed for up to 10 years. Based on their results, the
estimated structural valve degeneration rate was approximately 50% at 8 years. Beside the
clinical observations, several finite element computational simulations have been
performed to obtain stress and strain distributions of TAV leaflets (Abbasi and Azadani
2015, Abbasi et al. 2016, Li and Sun 2010, Martin and Sun 2015, Hsu et al. 2015, Xuan et
al. 2017, Abbasi and Azadani 2017). The simulation results showed higher mechanical
stress in TAVs compare to SAVs, affected by leaflet mechanical properties, design, and
thickness. As shown in this study, the pericardial leaflet thickness employed in TAVs is
less than that of surgical bioprostheses to accommodate TAVs to miniaturized catheters. A
reduction in leaflet thickness increases mechanical stress on the tissue and over time can
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negatively influence long-term durability of the TAVs. The increased mechanical stress
on TAV leaflets may explain the relatively higher rate of accelerated tissue degeneration
and diminished long-term durability in TAVs. However, the simulation results must be
validated by in-vivo clinical studies and by non-invasive in-vitro techniques such as DIC
measurements as presented in this study. In addition, it is important to note that in vitro
studies, such as the one presented here, only investigate the potential modes of valve failure
inherent to the design and materials used, and less towards the potential clinical modes of
failure.
5.4.4 Viscoelastic Behavior of Tissue Heart Valves
Biological soft tissue, including glutaraldehyde fixed bovine and porcine pericardial
tissues, are viscoelastic in nature and demonstrate a number of features including
hysteresis, creep, and force relaxation (Lee, Courtman, and Boughner 1984, Lee et al. 1994,
Talman and Boughner 1995). Considering the results of our experiments, the leaflets
showed viscoelastic behavior as manifested by different loading and unloading paths.
Histological characterization of the bovine and porcine pericardium has been carried out
in the past showing that the architecture of the pericardiums are similar consisting of
multiple layers of collagen bundles holding some degrees of fiber orientations (Gauvin et
al. 2013). In addition, it has been demonstrated that the large deformation response of
pericardial bioprosthetic materials is virtually unaffected by loading frequency (Lee et al.
1994), a phenomenon that we also observed in this study. As a result in computational
modeling, the viscoelastic behavior of tissue heart valves is often approximated by pseudohyperelastic material models (Fung 2013b). Although pseudo-elastic models seem
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reasonable to simulate biological soft tissues, high-quality experimental data from DIC
measurements are still needed to characterize the 3D anisotropic materiel models used in
the computational simulations.
5.5 Conclusions
In summary, an in-vitro DIC-based experiment was conducted to map displacement
and measure strain values on three different bioprosthetic heart valves, i.e., CarpentierEdwards PERIMOUNT Magna surgical bioprosthesis, Medtronic CoreValve, and Edwards
SAPIEN 3. High displacement regions were found at the leaflet belly region of the three
valves. In addition, frame of the surgical bioprosthesis was found to be noticeably flexible,
in contrary to CoreValve and SAPIEN 3, in which the stent was rigid. High strain regions
were found at the leaflet commissures in PREIMOUNT Magna and SAPIN 3. However,
the maximum strain value on CoreValve leaflets were found below the commissure region
close to the fixed boundary edge. The results of optical measurements in the DIC system
can be utilized to characterize the anisotropic materiel behavior of the leaflets and validate
computational simulations. The simulations would enable one to compare side-by-side
different bioprosthetic heart valves and to obtain high resolution stress and strain values
particularly close to the fixed boundary edge of the leaflets, a region which displacement
and strain measurements are not feasible by DIC measurements. Moreover, further studies
are motivated to measure leaflet deformation and strain fields under dynamic loading
conditions.
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Chapter 6: Material Characterization Framework for Commercial bioprostheses

6.1 Introduction
Pre-clinical assessment and verification of life sustaining implantable medical devices
such as prosthetic heart valves are essential and required by regulatory agencies. As a
result, in vitro bench-top and pre-clinical animal testing have been employed to verify
safety and improve design features of prosthetic heart valves . However, the pre-clinical
studies are time-consuming and costly, and therefore, the tests may potentially inhibit
exploration and use of novel materials and designs in prosthetic heart valves. In the past
few years, computational modeling and simulation have been widely employed to expedite
design and optimization of new medical devices (Fries 2016, Morris et al. 2016).
Computational simulations can play a pivotal role in design and development of prosthetic
heart valves by reducing the need to perform expensive pre-clinical tests. Furthermore,
regulatory agencies such as the U.S. Food and Drug Administration (FDA) and EU Medical
Device Regulatory System currently accept validated computational modeling and
simulation as a scientific evidence in regulatory submissions (Food and Administration
2014).
In the past decade, use of bioprosthetic heart valves for aortic valve replacement has
increased significantly (Mack and Holmes 2016).

The trend was due to promising

improvements in the long-term durability of surgical aortic valves (SAVs) and the advent
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of transcatheter aortic valves (TAVs) (Cribier et al. 2002, Isaacs et al. 2015). Randomized
clinical trials proved transcatheter aortic valve replacement (TAVR) improved survival
over medical therapy for inoperable patients with severe symptomatic aortic stenosis
(Kapadia et al. 2015, Leon et al. 2010, Makkar et al. 2012, Nishimura et al. 2014, Popma
et al. 2014). Furthermore, transfemoral TAVR showed equivalent or superior outcomes
when compared to surgical aortic valve replacement (SAVR) for the high-risk (Adams et
al. 2014, Kodali et al. 2012, Mack et al. 2015, Smith et al. 2011) and intermediate-risk
(Leon et al. 2016a, Reardon et al. 2016) patients. At present, large randomized clinical
trials are underway for low-risk surgical patients with aortic stenosis. However, durability
is the Achilles heel of bioprosthetic heart valves (Arsalan and Walther 2016, Bourguignon,
Bouquiaux-Stablo, et al. 2015, Dvir et al. 2016, Grunkemeier et al. 2012, Johnston et al.
2015).
Accurate and validated computational simulations can be effectively used to improve
structural and hemodynamic performance of bioprosthetic heart valves. The commercially
available bioprosthetic heart valves are made from materials such as metals (e.g., stainless
steel, cobalt alloys, and titanium-nickel alloy (Nitinol), polymers (e.g., Dacron and Teflon),
and fixed biological soft tissue (e.g., bovine and porcine pericardium). To have a reliable
computational model, considering accurate mechanical properties for the bioprosthetic
materials is a crucial step. In the past few decades, mechanical properties of bovine and
porcine pericardium have been obtained primarily using experimental methods such as
uniaxial and biaxial tensile tests(Abbasi and Azadani 2015, Sacks 2000, Sun, Abad, and
Sacks 2005). However, the planar tests cannot capture the out-of-plane mechanical
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behavior of the soft tissue (Holzapfel and Ogden 2008). In addition, due to extensive intraspecimen and inter-specimen variations (Hiester and Sacks 1998), mechanical properties
of examined materials in the pre-clinical tests may be significantly different from the actual
materials used in the implanted bioprosthetic valves. Consequently, employing optimized
material parameters to describe valve-specific mechanical behavior of the leaflets is
essential in computational simulations.
In the present chapter, we aimed to develop a non-invasive material characterization
framework using integrated experimental and numerical methods to determine mechanical
propertied of soft tissue employed in bioprosthetic heart valves. Accordingly, we
characterized three-dimensional anisotropic mechanical properties of leaflets used in two
commercially available TAVs (i.e., Edwards SAPIEN 3 and Medtronic CoreValve), and
compared the results to that of a commonly used and well-examined surgical bioprosthesis
(i.e., Carpentier-Edwards PERIMOUNT Magna aortic heart valve). In addition, the present
chapter presents a reliable approach to compare leaflet stress distribution among different
bioprostheses under physiological loading condition.
6.2 Materials and Methods
6.2.1 Commercial bioprostheses
In the present study, two commercially available TAVs and one surgical bioprosthesis
with comparable size were evaluated (Fig. 6.1). The first bioprosthetic valve was a 25-mm
Carpentier-Edwards (CE) PERIMOUNT Magna aortic heart valve (Edwards Lifesciences,
CA). The surgical bioprosthetic valve was made from bovine pericardium leaflets mounted
on an Elgiloy frame with an internal diameter of 24 mm. The second bioprosthesis was a
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self-expanding 26-mm Medtronic CoreValve (Medtronic, Minneapolis, MN), consists of
porcine pericardial leaflets mounted on a self-expanding Nitinol stent. The third
bioprosthetic valve investigated in this study was a 26-mm Edwards SAPIEN 3 (Edwards
Lifesciences, Irvine, CA). The TAV was constructed from bovine pericardial leaflets
mounted on a balloon-expandable cobalt-chromium stent. The thickness of the leaflets was
measured using Mitutoyo Digital caliper (Mitutoyo Corp, Kanogawa, Japan) and the
average thickness was 0.56 mm, 0.43 mm, and 0.32 mm for CE PERIMOUNT Magna
bioprosthesis, CoreValve, and SAPIEN 3, respectively.

Figure 6.1. (Left) 25-mm Carpentier-Edwards PERIMOUNT Magna surgical bioprosthetic
aortic valve. (Center) 26-mm Medtronic CoreValve. (Right) 26-mm Edwards SAPIEN 3
transcatheter heart valve.
6.2.2 Experimental Setup
6.2.2.1 Digital image correlation measurements
Due to the limited temporal and spatial resolution of the currently available in vivo
imaging modalities, in vitro tests play a central role in characterizing mechanical properties
of soft tissue and validate computational simulations. In view of that, high-resolution
optical techniques such as digital image correlation (DIC) can be utilized to quantify
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bioprosthetic valve leaflet displacement non-invasively under a well-defined loading
condition. In this chapter, a high-resolution GOM-ARAMIS stereovision DIC system
(GOM-Optical Measuring Techniques, Braunschweig, Germany) was used to obtain
displacement map of the bioprosthetic heart valves. The system consists of two high-speed
cameras with a resolution of 5 megapixels (2448 x 2050 pixels) equipped with 50 mm focal
length Titanar lenses. The top side of the leaflets were sprinkled with graphite to create a
speckled pattern (Fig. 6.2). Details of the DIC imaging and measurements have been
previously described in chapter 5. Briefly, the bioprosthetic valves were mounted inside an
optically clear acrylic chamber on a custom-made fixture. The valves were submerged fully
in the chamber and the leaflets were pressurized uniformly from 20 mmHg to 120 mmHg
using a peristaltic pump. Pressure in the chamber was measured continuously by a pressure
transducer, monitored by StatysTM software, and recorded simultaneously by a data
acquisition system. Pressure curves acquired from the DIC tests were shown in the Fig 5.5.
In addition, image acquisition was triggered simultaneously, and image series were
collected and stored using the ARAMIS DIC software at a frame rate of 10 frames per
second. Following image acquisition, image processing was performed using the ARAMIS
DIC software by discretizing all the images to a grid of square subsets of pixels called facet
point (FP). An identical facet size (19 pixels) was considered for all the three valves. A few
sample FPs (FP1 - FP6) are shown in Fig.6.2. Leaflet deformation was determined by
tracking the movement of the FPs. Three-dimensional surface contours of the displacement
map were determined with respect to a reference pressure configuration, i.e. chamber
pressure of 30-mmHg.
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Figure 6.2: Example of speckled pattern and facets points that were used for post
processing of the experimental data.
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6.2.2.2 In-vitro pulse duplicator system
The three bioprosthetic heart valves were also examined under dynamic physiological
loading condition in a custom-built pulse duplicator system (BDC Labs, Wheat Ridge,
CO). Details of the in vitro tests have been previously described in chapter 3. The pulse
duplicator input parameters matched the international standard ISO 5840: 2015
recommendations for testing prosthetic heart valves, i.e., heart rate of 70 beats/min, mean
atrial and aortic pressures of 10 and 100 mmHg, and cardiac output of 5 L/min. The
physiological flow condition was simulated by controlling local compliance and peripheral
resistance in the pulse duplicator. Recirculating fluid of 45% by volume glycerin solution
(99% glycerin, The Science Company, Denver, CO) in phosphate buffered normal saline
solution (PBS 100ml tablets, Research Products International, Mount Prospect, IL) was
used as a blood analog fluid at 37 °C. Transvalvular pressure waveform and flow rate of
the three bioprosthetic valves were measured from the in-vitro tests in Fig. 6.3.
Furthermore, the leaflet motion for the valves was captured by a using a high-speed camera,
SONY DSC-RX10M3 high-speed camera, at a rate of 960 frames per second. The images
were digitized in MATLAB, and the center of each leaflet was tracked and its distance with
respect to the center of the three valves was calculated through the entire cardiac cycle.
6.2.3 Computational Simulation
6.2.3.1 Finite element modeling
Leaflet geometry of the three bioprosthetic valves was obtained using NextEngine 3D
Laser Scanner with a resolution of 100 micrometers (NextEngine, Inc., Santa Monica, CA).
Surface reconstruction of valves was performed using RapidWorks and SOLIDWORKS
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Figure 6.3: Bioprosthetic pressure and flow rate waveforms, (Top) Carpentier-Edwards
PERIMOUNT Magna, (Middle) Medtronic CoreValve, (Bottom) Edward SAPIEN 3.
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packages, and IGES format of the leaflets were obtained for finite element (FE)
simulations. For mesh generation, the leaflets were imported to HyperMesh (Altair
Engineering, Inc., Troy, MI), and the geometry was discretized using a mapped mesh. The
mesh was subsequently imported to ABAQUS/Explicit solver. The leaflet thickness was
assumed uniform and constant throughout the leaflet. Material orientation was assigned to
the shell elements using a home-developed MATLAB code. Density of the leaflets was
considered to be 1,100 kg/m³ (Kim et al. 2008). Frame of the surgical bioprosthetic valve
was found to be flexible in the DIC tests in chapter 5. Therefore, a flexible frame with a
uniform diameter, measured by the caliper to be 0.89 mm, and density of 8,300 kg/m3 (Roy
and Chanda 2014) was considered in the FE simulations for the surgical bioprosthesis (Fig.
6.4). Due to the high radial strength of TAV frames, the stent of CoreValve and SAPIEN
3 was considered to be rigid. The rigidity of the TAV frames was confirmed by the DIC
measurements. The geometry of CE PERIMOUNT Magna bioprosthesis was meshed using
7,674 ABAQUS S4 shell elements and 345 B31 beam elements. The beam elements of the
surgical valve frame were connected to the leaflet using multi-point constraints. 11,166
and 8,250 ABAQUS S4 shell elements were used to discretize CoreValve and SAPIEN 3
bioprostheses, respectively. The number of elements in the simulations was adequate to
assure that the results are independent of mesh density.
To make sure the FE results are independent of mesh density, for each one of the
bioprosthetic heart valves, four mesh densities were evaluated by comparing the maximum
displacement of the middle point of the leaflet’s free-edge and its maximum principle stress
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Figure 6.4: Representative FE models for (Left) Carpentier-Edwards PERIMOUNT
Magna, (Center) Medtronic CoreValve, (Right) Edward SAPIEN 3.
value. As an example, please see below in Table 6.1 and Fig. 6.5, analysis of mesh
density for SEIPEN 3 at a point in the systole. The difference in normal displacement and
maximum stress between mesh density (#3) and (#4) was less than 0.14% and 0.5%,
respectively. Therefore, mesh density (#3) was considered in the FE simulations. A similar
analysis was conducted for the CoreValve and the CE PREIMOUNT Magna bioprosthesis.
Transvalvular pressure gradient waveforms obtained from the in-vitro tests were
applied to the ventricular side of the leaflets. Moreover, a Rayleigh damping coefficient n
was introduced to the simulations to mimic viscous damping effects of surrounding fluid.

Table 6.1: Independence of the FE simulation of SAPIEN 3 from computational grid
density.
Number

Number of elements
(one leaflet)

Displacement (m)

Maximum principal
stress(Pa)

1
2
3
4

1008
2238
2750
4040

0.00340988
0.00342635
0.00345985
0.00345501

1171250
1262410
1280560
1287020
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Figure 6.5: Maximum displacement of the middle point of the SAPIEN 3 leaflet’s freeedge.
In the FE simulations, bioprosthetic leaflets were considered to be pseudo-hyperelastic
anisotropic materials (Abbasi and Azadani 2015, Abbasi and Azadani 2017). There are two
forms of strain energy potentials available in ABAQUS/Explicit to characterize anisotropic
materials: (i) generalized three-dimensional Fung strain-energy function proposed by
Humphrey (Humphrey 1995) and (ii) Holzapfel-Gasser-Ogden (HGO) strain energy
function which was developed as a framework to model arterial layers with distributed
collagen fiber orientation(Holzapfel 2000). A generalized Fung strain-energy function is
in the form
1=

@ A
1 8#  − 1
( − 1) + (
− ln 8# )
2
B
2

(6.1)

where 1 is the strain energy per unit of reference volume. Details of the generalized Fung
strain-energy function have been previously described in chapter 3. On the other hand, the
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strain energy function for HGO model also known as Holzapfel model in ABAQUS
consists of two terms: (i) isochoric and (ii) volumetric parts. The isochoric part is further
decomposed into distinct matrix and fiber material terms with the following function
c
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(6.3)

is the parameter of the isotropic neo-Hookean term which affects the stiffness

of the isotropic hyperelastic matrix; c , c are temperature-dependent material parameters
which determine the stiffness and exponential response of the collagen fiber networks in
the material, respectively; B is the compressibility parameter; ¦ describes the level of

dispersion in the fiber directions (0 ≤ ¦ ≤ 1⁄3 ); ¨ is the number of families of fibers

̅
(¨ ≤ 3 ); .̅ is the first deviatoric strain invariant; and .,()
are pseudo-invariants of the
right Cauchy Green tensor and a set of unit vectors for the fiber directions. The structural
̅
anisotropy induced by the fiber network originates from .,()
. The HGO model can be
defined by five parameters (

 ,

c , c , ¦, B). In this study, B was assumed to be a

constant value of 10-5 for the bioprosthetic valve leaflets(Martin and Sun 2015).
6.2.3.2 Optimization framework
To determine 3D mechanical properties of the leaflets, a two-step global optimization
approach was utilized. The flowchart in Fig. 6.6 shows how the optimization technique
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was implemented to find the material parameters. We used leaflet material properties
reported in Abbasi and colleagues (Abbasi et al. 2016) and Martin and Sun (Martin and
Sun 2015) as initial estimate values of the optimization for Fung and HGO models,
respectively. In the first step, the DIC measurements were utilized to determine leaflet
material coefficients in both Fung and HGO models. The stent of CoreValve and SAPIEN
3 was considered to be rigid. However, for the surgical bioprosthesis a linear elastic frame
was considered in the simulations. The Young's modulus of the frame was taken as an
adjustable parameter in the optimization to match displacement of the frame obtained from
the DIC tests. The Poisson's ratio of the frame was considered to be 0.226 (Roy and Chanda
2014). The material coefficients were obtained by minimizing the error norm of
displacement field between DIC measurements and FE simulations for the six facet points,
selected in the belly region and region close to the free edge of the leaflets as shown in Fig.
6.2, using particle swarm optimization (PSO) (Banks, Vincent, and Anyakoha 2008)
method implemented in Isight (Simulia, Providence, RI). Six facet points provided a
reasonable balance between the complexity of the analysis (i.e., computational cost) and
accuracy of the computational model. Equal weight was considered for all the facet points.
The optimization process terminated when the change of the objective function was less
than the set tolerance of 10-5. Approximately, 500 iterations were performed to achieve
convergence. The displacement contour plots obtained by the optimized material
coefficients were then compared with experimental displacement contours obtained from
the DIC tests. A material model that showed a good agreement with the experimental data
was then considered for the second step of optimization. In the second step, the leaflet
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Figure 6.6: Flowchart for parameter estimation algorithm.
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material parameters plus the viscous damping coefficient were optimized based on the raw
(unfiltered) hemodynamic data (i.e., pressure waveforms) obtained from the pulse
duplicator system using PSO method in Isight. The middle point distance of leaflets with
respect to the center of the valve in the FE simulation was matched with the experimental
measurements in the pulse duplicator system. To reduce computational cost, only one
cardiac cycle was simulated, and one leaflet motion was considered in the optimization
procedure during valve opening and closing. The optimization process was set to be
terminated when the change of the objective function was less than the set tolerance of
10-5.
6.3 Results
6.3.1 Estimated Material Parameters of Leaflets
The two-step optimization procedure was used to determine 3D mechanical properties
of the bioprosthetic valve leaflets. First, DIC tests were simulated to obtain appropriate
initial estimate values for the material coefficients in both Fung and HGO models. Material
coefficients were obtained by minimizing the simulated and measured displacement
vectors of the six facet points (Figs. 6.7-6.9). The results of material optimization are
shown below for 3D anisotropic Fung model. Furthermore, the estimated values for @
coefficient in the Fung model are presented in Table 6.2. In addition, the results of material
optimization for HGO model are shown in Table 6.3. For the three bioprosthetic heart
valves, the curve fit of the generalized Fung model was to some extent better than the HGO
model (Figures 6.7-6.9 and Table 6.4). In addition to the six facet points, to evaluate the
overall accuracy of the two constitutive models, displacement contour plots of the leaflets
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Figure 6.7: Displacement-time curves of the six facet points on the leaflets of CarpentierEdwards PERIMOUNT Magna.
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Figure 6.8: Displacement-time curves of the six facet points on the leaflets of Corevalve.
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Figure 6.9: Displacement-time curves of the six facet points on the leaflets of Edward
SAPIEN 3.
were obtained from the FE simulations and compared with the displacement contour plots
obtained from the DIC tests. As shown in Figure 6.10, the anisotropic Fung model
simulated the surgical valve leaflet displacement better than the HGO model. Therefore, at
the end of first step of the optimization, between the two constitutive models, the 3D
anisotropic Fung model was chosen for the second step of the optimization procedure.
124

Table 6.2: Material parameter (c) coefficient for the Fung model after the first-step of the
optimization procedure.
Bioprosthesis

¹ (kPa)

CE PERIMOUNT Magna

171.10

CoreValve

105.53

SAPIEN 3

52.32

Table 6.3: Optimized Holzapfel-Gasser-Ogden model parameters after the first-step of the
optimization procedure.
Bioprosthesis

ºT» (kPa)

¼T (kPa)

¼U

½

CE PERIMOUNT Magna

1457.56

584.76

820.64

0.299

CoreValve

764.27

1166.40

3986.86

0.292

SAPIEN 3

1772.98

1058.47

984.19

0.287

Table 6.4: Optimization objective functions based on the DIC measurements.
Bioprosthesis

Fung

Holzapfel-Gasser-Ogden

CE PERIMOUNT Magna

5.43E-06

1.43 E-05

CoreValve

1.55 E-06

4.41 E-06

SAPIEN 3

3.77 E-06

1.92 E-05

In the second step, bioprosthetic leaflet deformation was simulated under dynamic
physiological loading condition that was obtained from in vitro tests in the pulse duplicator
system. The range of initial values in the second step of the optimization was
0.8 × F(&sq9q#t rt&&¾o&rp #q&o#) ≤ F ≤ 1.2 × F(&sq9q#t rt&&¾o&rp #q&o#) ,

0.9 × @(&sq9q#t rt&&¾o&rp #q&o#) ≤ @ ≤ 1.1 × @(&sq9q#t rt&&¾o&rp #q&o#) , and
1000 ≤ n ≤ 11000. Three-dimensional generalized anisotropic Fung model parameters
of the leaflets and Rayleigh damping coefficient for the three bioprostheses were estimated
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Figure 6.10: Comparison of displacement contour plots of PERIMOUNT Magna leaflets obtained
from the FE simulations and DIC test at pressures of 40, 60, 80,100 and 120 mmHg.

using PSO method in Isight by matching the middle point distance of one leaflet in the FE
simulations with the averaged experimental data (Fig. 6.11). After another 500 iterations,
the optimization results showed a reasonable agreement with the experimental data. The
estimated material parameters of the leaflets for the three heart valves are listed below for
the 3D anisotropic Fung model. In addition, the estimated values for  and the viscous
damping coefficient are presented in Table 6.5.
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In addition, after completing the second optimization step, the optimized material
coefficients were double checked to make sure both convergence criteria are met. As an
example, in the CE PERIMOUNT Magna bioprosthesis, the displacement of three facet
points in the commissure (FP1), free edge (FP4), and belly region (FP6) are shown below
in Fig. 6.12 based on the coefficients obtained from the first- and second-step of the
optimization procedure.
6.3.2 Leaflet stress distribution
Using the optimized parameters, the maximum in-plane principal stress distribution of
25-mm CE PERIMOUNT Magna, 26-mm CoreValve, and 26-mm SAPIEN 3 were
obtained and shown separately in Figure 6.13, 6.14, and 6.15, respectively. Two cardiac
cycles were simulated to guarantee cycle invariance. The left-side columns depict the
images of valve opening and closing in the pulse duplicator, captured by the high-speed
camera. In the systole, high stress regions were primarily observed in the fixed boundary
edges of the three bioprostheses. The peak leaflet stress value during systole for the CE
PERIMOUNT Magna, CoreValve, and SAPIEN 3 reached to 3.29, 7.25 and 7.53 MPa,
respectively. During diastole, the peak stress value of the PERIMOUNT Magna,
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Figure 6.11: Middle point displacement of the leaflet for the three valves; comparing
optimized FE simulations with the experimental data. The average standard deviation for
the three leaflets based on the experimental data was ± 0.38, ± 0.35, and ± 0.18 mm for the
CE PERIMOUNT Magna, CoreValve, and SAPIEN 3, respectively.
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Figure 6.12: Displacement of three facet points in the commissure (FP1), free edge (FP4), and belly
region (FP6) of Magna bioprosthesis based on coefficients obtained from the first- and second-step
of the optimization procedure.
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Table 6.5: Material parameter and viscous damping coefficient for 3D anisotropic Fung
model.
Bioprosthesis

¹ (Material parameter, kPa)

 (Viscous damping, 1/s)

CE PERIMOUNT Magna

90.72

10642

CoreValve

100.29

8313

SAPIEN 3

47.53

4800

CoreValve, and SAPIEN 3 leaflets reached to 0.99, 1.01 and 2.53 MPa, respectively. In
CE PERIMOUNT Magna and Edwards SAPIEN 3, the high stress regions were observed
close to the commissures in the fully closed position. For Medtronic CoreValve, however,
the maximum stress values were observed in the lower leaflet belly region.
To compare the leaflet stress distribution among the three bioprostheses, contours of
maximum in-plane principal stress of the leaflets were determined at an identical pressure
gradient in the diastole and systole (i.e., 16kPa and 3.3kPa). As shown in Figure 6.16A, the
peak of maximum in-plane principal stress in the diastole was 0.98, 0.96 and 2.95 MPa for
the CE PERIMOUNT Magna, CoreValve, and SAPIEN 3, respectively. It can be seen that
CoreValve had the lowest peak stress value at the identical pressure value during diastole.
Figure 6.16B, further demonstrates that the value of peak stress reached to 1.64, 4.14, and
6.87 MPa at the pressure gradient 3.3kPa (≈ 25 mmHg) in the systole for the PERIMOUNT
Magna, CoreValve, and SAPIEN 3 valves, respectively. Unlike diastole, the peak stress in
the PERIMOUNT Magna valve was significantly lower than the CoreValve and SAPIEN
3 bioprostheses. Moreover, to quantify the difference in stress distribution among the three
valves at the identical pressure gradient, the maximum in-plane principal stress histogram
of the leaflets was presented in Figure 6.17. SAPIEN 3 had significantly more elements
with stress values higher than 600 kPa (35.7%) compared to the PERIMOUNT Magna and
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CoreValve. In addition, 12.7% of elements in SAPIEN 3 had stress values higher than
1,000 kPa (1MPa).

On the other hand, 94.9% and 98.7% of elements in the CE

PERIMOUNT Magna and CoreValve had stress values of less than 600 kPa, respectively.
At the systole, 7.5%, 8.0 % and 12.7% of elements in the PERIMOUNT Magna, CoreValve
and SAPIEN 3 models reached to stress values higher than 600 kPa, respectively. This
observation demonstrates many elements with high stress values during diastole may affect
long-term valve durability more than the systole phase. However, the maximum leaflet
stress during diastole was 40%, 77% and 57% less than the maximum principal stress
during systole for the PERIMOUNT Magna, CoreValve, and SAPIEN 3 valves,
respectively.
6.4 Discussion
6.4.1 Summary
In the present chapter, we presented a non-invasive material characterization
framework to determine mechanical propertied of soft tissue employed in bioprosthetic
heart valves. We characterized three-dimensional anisotropic mechanical properties of
leaflets used in two commercially available TAVs (i.e., Edwards SAPIEN 3 and Medtronic
CoreValve), and compared the results to that of a commonly used and well-examined
surgical bioprosthesis (i.e., Carpentier-Edwards PERIMOUNT Magna aortic heart valve).
High resolution DIC was used to quantify bioprosthetic valve leaflet displacement under a
well-defined loading condition. In addition, the bioprosthetic valves were examined under
dynamic physiological loading condition in a pulse duplicator system. A two-step iterative
optimization approach was then utilized to determine 3D anisotropic mechanical properties
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Figure 6.13: Comparison of in-vitro leaflet motion with FE simulations throughout a
complete cardiac cycle for the valves. The left plot represents flow curve. (Left column)
Experimental data (Middle and right columns) the maximum principal stress distributions
on the valve based on Fung-anisotropic model, Carpentier-Edwards PERIMOUNT Magna.
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Figure 6.14: Comparison of in-vitro leaflet motion with FE simulations throughout a
complete cardiac cycle for the valves. The left plot represents flow curve. (Left column)
Experimental data (Middle and right columns) the maximum principal stress distributions
on the valve based on Fung-anisotropic model, Medtronic CoreValve.
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Figure 6.15: Comparison of in-vitro leaflet motion with FE simulations throughout a
complete cardiac cycle for the valves. The left plot represents flow curve. (Left column)
Experimental data (Middle and right columns) the maximum principal stress distributions
on the valve based on Fung-anisotropic model, Edward SAPIEN 3.
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Figure 6.16: Maximum in-plane principal stress contour plots of (Left) Carpentier-Edwards
PERIMOUNT Magna, (Center) Medtronic CoreValve, (Right) Edward SAPIEN 3 (A)
Diastole at the pressure gradient 16kPa (≈ 120 mmHg) (B) Systole at the pressure gradient
3.3kPa (≈ 25 mmHg).
of the leaflets. Using the optimized material parameters, the maximum in-plane principal
stress distribution of the three bioprostheses were obtained and compared during both
systole and diastole.
6.4.2 Long-term Durability
In the past few years, use of bioprosthetic valves for aortic valve replacement has
increased considerably (Mack and Holmes 2016). To choose an appropriate bioprosthetic
heart valve for aortic valve replacement, long-term durability of tissue heart valves is an
important factor. Especially, to expand the reach of TAVR into low-risk younger patients,
long-term durability of TAVs must be comparable to surgical bioprostheses. In surgical
bioprosthetic valves, leaflets degenerate through two distinct but potentially synergistic
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Figure 6.17: The maximum in-plane principal stress histogram of the leaflets.
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mechanisms: (i) calcification and (ii) fatigue-induced structural deterioration (Schoen et al.
1985, Schoen 2012). Since the commercially available TAV leaflets are made from
chemically treated bovine or porcine pericardium tissue, it can be postulated that the
structural deterioration of TAVs occurs via the two failure mechanisms. Although, a
unified definition of structural valve degeneration does not exist in the literature, the rate
of structural valve degeneration in surgical bioprostheses is known to be less than 15% at
10 years (Rodriguez-Gabella et al. 2017). In a retrospective cohort study, Forcillo and
colleagues (Forcillo et al. 2013) studied 2,405 patients with a mean age of 71 ± 9 years old
who underwent aortic valve replacement with Carpentier-Edwards surgical pericardial
bioprostheses. They found that the overall freedom rate of valve reoperation for valve
dysfunction averaged 96% ± 1% and 67% ± 4% at 10 and 20 years, respectively. In
addition, it is well known that the rate of reoperation for surgical valve dysfunction is
strongly affected by age. Bourguignon and colleagues (Bourguignon, El Khoury, et al.
2015) showed that the freedom from reoperation rates attributable to structural valve
deterioration in patients aged 60 or younger who received CE PERIMOUNT aortic valve
were 88.3% ± 2.4% and 38.1% ± 5.6% at 10 and 20 years, respectively. On the other hand,
clinical data regarding long-term durability of TAVs beyond 5 years is still limited. Dvir
and colleagues (Dvir et al. 2016) recently demonstrated the estimated structural valve
degeneration rate of Cribier-Edwards, Edwards SAPIEN, and Edwards SAPIEN XT was
approximately 50% at 8 years. In addition, Toggweiler and colleagues (Toggweiler et al.
2013) reported that 9.7% of living patients in the study had moderate prosthetic valve
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failure after 5 years. On the other hand, the 5-year rate of prosthesis failure was 1.4% with
the Medtronic CoreValve device (Barbanti et al. 2015).
6.4.3 Computational Modeling
Computational modeling and simulation can provide qualitative and quantitative
insights into the durability of bioprosthetic heart valves (Rabkin and Hsu 1975, Sacks,
Zhang, and Wognum 2016, Soares et al. 2016, Zhang and Sacks 2017, Zioupos and
Barbenel 1994). In the presence of limited clinical follow-up data for TAVs, several
computational simulations have been performed to obtain stress and strain distributions of
TAV leaflets (Abbasi and Azadani 2017, Abbasi and Azadani 2015, Abbasi et al. 2016,
Hsu et al. 2015, Jermihov, Jia, Sacks, Gorman, Gorman III, et al. 2011, Martin and Sun
2015, Xuan et al. 2017). The simulation results showed higher mechanical stress in TAVs
compare to surgical bioprosthetic valves. The increased mechanical stress on the leaflets
may explain the relatively higher rate of accelerated tissue degeneration and diminished
long-term valve durability. Considering the results presented in this study, there might also
be a difference in the long-term durability of different TAV models and designs, as
previously observed in clinical studies (Barbanti et al. 2015, Toggweiler et al. 2013).
However, due to the limited number of valves examined in this study, it is prudent not to
over-interpret the simulation results. The results must be validated by retrospective cohort
studies to confirm the findings in presence of calcification and other patient related factors.
Accuracy of computational modeling and simulations depends on the accuracy of the
prescribed material properties for the fixed bovine and porcine pericardium leaflets
(Humphrey 2003). Regional structural and compositional heterogeneity has been observed
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in pericardium leaflets (Billiar and Sacks 2000, Sacks 2000, Simionescu, Simionescu, and
Deac 1993). 3-D anisotropic constitutive models should therefore be considered for the
fixed-biological tissue to fully describe the three-dimensional mechanical properties of the
leaflets. Non-invasive material characterization methods, such as the one presented in this
chapter and other published studies (Abbasi et al. 2016, Murdock, Martin, and Sun 2018,
Aggarwal and Sacks 2016, Lee et al. 2014), can be used to determine the out-of-plane and
shear coefficients of the bioprosthetic heart valve leaflets. In addition, it is imperative to
evaluate bioprosthetic heart valves under dynamic loading condition to elucidate failure
mechanism in bioprostheses. Simplified loading conditions, e.g. quasi-static loading, may
not represent the true loading condition that the valves are exposed to following
replacement in clinical practice. Moreover, experimental validation of the computational
simulations should be an indispensable part of evaluation.
6.5 Conclusions
In summary, we developed a two-step optimization procedure to determine 3D
anisotropic mechanical properties of pericardial valves under physiological loading
conditions. Three different bioprosthetic heart valves with comparable size were
investigated. The optimized material parameters for each valve were implemented in FE
simulations to assess the leaflet deformation and stress distribution. During systole, high
stress regions were primarily observed at the boundary edge for the bioprostheses.
However, during diastole, high stress regions were primarily observed in the commissures
for CE PERIMOUNT Magna and Edwards SAPIEN 3. In contrary to the two other
bioprostheses, the maximum stress values for the CoreValve were seen in the lower leaflet
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belly region. In addition, the CoreValve had the lowest peak stress value at the identical
pressure value during diastole compared to the CE PERIMOUNT Magna and Edwards
SAPIEN 3. The present work presents a reliable approach to compare leaflet stress
distribution among different bioprostheses. Further studies are also motivated to obtain 3D
anisotropic mechanical properties of pericardial leaflets under physiological loading
condition using fluid-solid interaction simulations.
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CHAPTER 7: GEOMETRY OPTIMIZATION FRAMEWORK FOR TAV LEAFLET
SHAPE
7.1 Introduction
Durability of tissue heart valves results primarily from their ability to resist two distinct
yet potentially synergistic failure mechanisms (i) calcification and (ii) fatigue-induced
structural deterioration (Schoen and Levy 1999b). Since most of the TAV devices are
fabricated from chemically treated bovine or porcine pericardium tissue, it can be
postulated that the structural deterioration of TAVs occurs via the two failure mechanisms.
It has been shown that mechanical stress on bioprosthetic heart valve leaflets can be linked
with the leaflet degeneration (Levy et al. 1983, Schoen et al. 1985, Schoen and Levy
1999b, Sacks and Schoen 2002b). There is a correlation between the regions of tissue
rupture in bioprosthetic heart valves and excessive mechanical stress on the leaflets (Sacks
and Schoen 2002a, Ferrans et al. 1978a, Sacks 2001, Schoen et al. 1987). Moreover, it is
widely accepted that high stress regions initiate calcification by damaging the structural
integrity of tissue (Levy et al. 1983, Schoen and Levy 1999b, Schoen et al. 1985).
Therefore, proper evaluation of the leaflet stress distribution is essential to assess longterm durability of TAV devices (Zhang and Sacks 2017, Soares et al. 2016, Abbasi et al.
2016, Abbasi and Azadani 2015).
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Minimizing the peak stress valve in bioprosthetic heart valve leaflets is a crucial to
maximize long-term durability of the tissue heart valves (Vesely 2003). Therefore,
parametric studies on the effect of leaflet geometry on valve peak stress have been inspired
and developed (Li and Sun 2017, Hsu et al. 2015, Xu et al. 2017). In the present chapter,
we aimed to develop an automatic optimization framework using commercially available
software packages to assess the impact of TAV leaflet design on the maximum stress value
of the leaflets under dynamic physiological loading conditions. Optimized leaflet designs
were achieved for two different commonly-used TAV sizes (i.e., 23 mm and 26 mm).
Subsequently, the optimized leaflet designs were compared with two commercially
available

bioprostheses

(i)

Carpentier-Edwards

PERIMOUNT

Magna

surgical

bioprosthesis and (ii) Edwards SAPIEN 3 transcatheter heart valve, both are considered as
gold-standard devices in today’s practice of heart valve replacement.
7.2 Materials and Methods
7.2.1 Parameterization and Optimization of The TAV Leaflet Geometry
An automated geometry optimization framework was developed to reduce TAV leaflet
stress under physiological loading condition. TAV leaflets with uniform thickness (t) were
considered to be attached to a frame with a uniform thickness of 0.5 mm and an external
diameter of D. Two different external diameters (D) were considered in this study (i) 23
mm and (ii) 26 mm. Design variables were defined using two second-order Non-uniform
rational B-splines (NURBS) curves. As shown in Fig. 7.1, the approach provides effective
and reliable method to explore all possible geometrical configurations for the TAVs with
only 6 parameters: valve height (H), leaflet coaptation height (h), and two control points
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for each one of the two second-order B-splines (i.e., bq and ¿q for B-spline 1 in the plane
of symmetry (Plane 1), and bh and ¿h for B-spline 2 in Plane 2 which is tangent to the TAV
frame as shown in Fig. 7.1). In parameterization procedure, B-spline 2 was subsequently
projected on the cylinder, the TAV frame, to create a fixed-boundary edge for the leaflet.

Figure 7.1. Design variables in parameterization of the TAV leaflet geometry.
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The B-splines control points determine the shape of the fixed-boundary edge and the
symmetric curve. Afterward, the leaflet free-edge that connects the commissure to the point
of leaflet coaptation was reconstructed automatically based on the fixed-boundary edge
and the symmetric curve. A small gap (g) with a constant value of 0.6 mm was considered
at the center of the leaflets at the load-free initial configuration (Fig. 7.1). For mathematical
formulation and further details of the parameterization in MATLAB, please refer to the
supplementary materials.
The flowchart shown in Fig. 7.2 shows how the optimization procedure was
implemented in this study. Using an ABAQUS Python script, the curves generated in
MATLAB were imported into SolidWorks. Due to the symmetry of the TAV leaflet design,
the fixed-boundary edge and the leaflet free-edge were mirrored with respect to the plane
of symmetry (Plane 1). Then, a surface was created based on the boundary curves of the
leaflet using Filled Surface command in SolidWorks (Fig. 7.3). The symmetric curve was
used as a constraint curve in the procedure. Subsequently, the constructed leaflet was
rotated ± 120° about the center of the TAV frame to create the other two leaflets (Fig. 7.3).
Then using an ABAQUS Python script, the valve geometry was imported to ABAQUS and
discretized using S4 and S3 shell elements. In the Python script, the average size of mesh
in finite element (FE) simulations was set to be 0.3 mm. Due to high radial strength of TAV
frames that is needed to provide positional stability of the valves (Abbasi et al. 2018b), the
stent frame was considered to be rigid. As a result, all nodes along the fixed-edge curve
were considered to be fixed in the FE simulations. In addition, a uniform leaflet thickness
of 0.5 mm was considered in the simulations. Furthermore, a physiological transvalvular
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Figure 7.2. Flowchart for the optimization framework of the TAV leaflet geometry.

Figure 7.3. Reconstruction of the leaflet geometry in SolidWorks.
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Figure 7.4. Variation in pressure in the left ventricle (red dashed line) and the aorta (blue
solid line). The wave pressure (green dash-dot line) is defined as the pressure difference
between the left ventricle and the aorta.
pressure gradient was applied to the leaflets as a loading condition (Fig. 7.4) (Abbasi and
Azadani 2015).
In the optimization process, TAV leaflets were considered to be isotropic nonlinear
hyperplastic material. A fourth-order reduced polynomial strain-energy function was fitted
to experimental raw data obtained from biaxial testing of bovine pericardium samples,
previously reported by our group (Abbasi and Azadani 2015).
  ∑,&-
Where

&

̅ − 3)&

& .

(1)

are constants and À. is the first principal invariant of the left Cauchy–Green

deformation tensor (See Table 7.1).
Table 7.1: Coefficients of fourth-order reduced polynomial strain-energy function.
C10

C20

C30

C40

1.56941E+5

8.59024E+5

-6.50847E+5

5.59565E+6
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The objective of the optimization technique was minimization of the squared root of
maximum von Mises stress Áo , defined based on the following equation:
Áo  ÂÁ q
Where Á q

qr #

qr #



+ Á Ã&oqr # 

(2)

and Á Ã&oqr # were the maximum Von Mises stress at the peak of systole

and the peak diastolic pressure, respectively. To reduce the bending stress including tensile
and compressive stresses within the leaflets of TAVs, the maximum Von Mises stress is
the most appropriate objective value to be minimized in the optimization procedure.
Particle swarm optimization method, a built-in algorithm in Isight, was used in the
optimization procedure. Range of design parameters for two TAV sizes is listed in Table
7.2. Approximately, 500 iterations were required to reach convergence for each one of the
TAV sizes.
Table 7.2: Range of design parameters in the optimization procedure.
Parameters
Ê = 23 mm
Ê = 26 mm

Ä (mm)

Å (mm)

ÆÇ (mm)

ÈÇ (mm)

ÆÉ (mm)

ÈÉ (mm)

10.3 ~ 12.3

7.0 ~ 9.0

9.0 ~ 12.7

0.0 ~ 1.0

7.0 ~ 11.0

0.0 ~ 6.0

14.0 ~ 16.00

10.0 ~ 12.5

9.0 ~ 12.7

0.0 ~ 1.0

7.0 ~ 11.0

0.0 ~ 6.0

7.2.2 Comparison with The Commercially Available Bioprosthetic Heart Valves
After completing the optimization procedure, the optimized 23-mm and 26-mm leaflet
geometries were compared with comparable size Carpentier-Edwards PERIMOUNT
Magna surgical bioprostheses. In addition, the 26-mm optimized leaflet geometry was
compared with 26-mm Edwards SAPIEN 3 transcatheter heart valve. To compare leaflet
147

stress distribution, a 3-D generalized anisotropic Fung-type hyperelastic material model
was used to characterize the anisotropic behavior of the leaflets. A generalized Fung strainenergy function in 3-D space is in the form
@ A
1 8#  − 1
1  ( − 1) + (
− ln 8# )
2
B
2

(3)

where 1 is the strain energy per unit of reference volume. B and @ describe the
temperature-dependent material parameters, 8# stands for the elastic volume ratio which is
equal to 8 in the absence of thermal strains, and A is given by
A = 6: (F6)

(4)

where F is a non-dimensional symmetric fourth-order tensor of anisotropic material

constants, and 6 is the Green-Lagrange strain tensor, under the assumption of tissue
incompressibility. Considering the incompressibility assumption (8# = 1), the Fung strain

energy function is reduced to
1=

@ 
( − 1)
2

(5)

The number of components of that must be determined is similar to the elasticity tensor,
namely 21 independent components for a 3-D generalized anisotropic Fung strain-energy
function as shown below.
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The following material coefficients previously reported in the literature for the
bioprostheses were considered in this study (Abbasi et al. 2016, Abbasi and Azadani 2017)
and chapter 6 in this dissertation.

Fd||9©ª«¬®¯°± G²HG

FË||9©ª«¬®¯°± G²HG

FÌ||9·¸©¬ª° d

R
Q
=Q
Q
Q
P

R
Q
=Q
Q
Q
P

R
Q
=Q
Q
Q
P

62.95

63.42

87.45

36.39
61.88

54.14 17.13
45.64 68.15
65.98 38.70
14.40
Symmetric

31.84
63.74

51.29 17.37
46.75 68.38
62.82 38.51
14.30
Symmetric

37.88
83.97

56.25 18.49
43.50 70.21
89.93 43.70
13.92
Symmetric

45.45
67.97
63.95
16.26
42.57
49.02
63.09
60.17
15.47
47.30

45.47
71.65
62.41
15.12
43.54

41.72
_
23.42^
56.17^,
27.56^
17.61^
60.66]

39.39
_
19.22 ^
55.50 ^,
28.04^
13.69^
67.53]

37.23
_
25.72 ^
58.98 ^.
27.96^
16.47^
68.56]

In addition, the estimated values for c is presented in Table 7.3. For the surgical
bioprostheses, a flexible frame with a uniform diameter (0.89 mm) and density (8,300
kg/m3) was considered in the FE simulations. To compare the leaflet stress distribution
between the commercially available bioprostheses and the optimized leaflet geometry, it
was assumed that the leaflets have identical mechanical properties and thickness in each
pair of comparisons. Contours of maximum in-plane principal stress of the leaflets were
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Table 7.3: Material parameter for the 3D anisotropic Fung models.
¹ (kPa)

Bioprosthesis
23-mm PERIMOUNT
Magna
25-mm PERIMOUNT
Magna

24.62
90.72
47.53

26-mm SAPIEN 3

then determined at an identical pressure gradient across the valve (i.e., 16kPa ~120 mmHg).
To avoid the mesh density sensitivity, the number of elements in the FE simulations were
comparable for each pair of comparison groups.
7.3 Results
7.3.1 Optimization Results
The objective of the optimization procedure was to minimize the square root of
maximum Von Mises stress (Áo  on the TAV leaflets. As shown in Fig. 7.5, there was a
significant difference in the magnitude of Áo within the design domain. The maximum
value of Áo was 2.46 and 2.41 MPa, while the minimum value of Áo was 1.30 and
1.29 MPa for the 23-mm and 26-mm TAVs, respectively. Áo reached to its minimum
value after 451 and 477 iterations for 23-mm TAV and 26-mm TAV, respectively. The
minimum value of Áo , hereafter referred to as the best leaflet design, was 47.2% and
46.5% less than maximum value of Áo , hereafter referred to as the worst leaflet design,

for the 23-mm and 26-mm TAVs, respectively. In addition, for the best and the worst leaflet
design configurations, the maximum Von Mises stress at the peak of systole (Á q

peak of diastolic pressure (Á Ã&oqr # ) are listed in Table 7.4.
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qr # )

and

Figure 7.5. An overview of the optimization process. The square root of maximum von
Mises stress (S_max) versus the number of iterations for (A) 23-mm TAV (B) 26-mm
TAV.
Table 7.4: The stress values for the best and worst designs of 23 and 26 mm TAVs.
23-mm TAV
(best leaflet design)
23-mm TAV
(worst leaflet design)
26-mm TAV
(best leaflet design)
26-mm TAV
(worst leaflet design)

7 ÉÍÉÎÏÐÑ (MPa)

7 ÒÓÔÉÎÏÐÑ (MPa)

7ÕÔÖ (MPa)

0.92

0.91

1.30

1.22

2.14

2.46

0.97

0.86

1.29

1.02

2.19

2.41
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7.3.2 The Best Design and Commercial Bioprostheses
After completing the optimization procedure, to compare leaflet stress distribution
between the commercially available bioprostheses and the best leaflet design
configuration, contours of the maximum in-plane principal stress of the leaflets were
obtained and presented in Fig. 7.6. As shown in Fig. 7.6A, high stress regions were
observed close to the commissures. The peak leaflet stress value for the 23-mm CarpentierEdwards with a flexible frame reached to 0.98 MPa. However, the maximum in-plane
stress of the best leaflet design with rigid stent was 0.9 MPa. In other words, there was an
8.2% reduction in the peak in-plane maximum principal stress in the optimized TAV
geometry. An identical uniform thickness of 0.5 mm and material property were considered
for the two models. Stress in the belly region was also lower in the best leaflet design than
the 23-mm Carpentier-Edwards PERIMOUNT Magna surgical bioprosthesis.
A similar trend was observed with the 26-mm TAV (Fig. 7.6B). The maximum inplane stress of the best leaflet design with rigid frame was 0.69 MPa, while the maximum
in-plane stress for the 25-mm Carpentier-Edwards PERIMOUNT Magna surgical
bioprosthesis with flexible frame was 0.99 MPa. In other words, there was a 30.3%
reduction in the peak in-plane maximum principal stress in the optimized TAV geometry.
Both models had an identical leaflet thickness of 0.56 mm and leaflet mechanical
properties. Stress in the belly and commissure regions was lower in the best leaflet design
compare to the 25-mm Carpentier-Edwards PERIMOUNT Magna surgical bioprosthesis
(Fig. 7.6B). Lastly, the optimized 26-mm TAV was compared with 26-mm Edwards
SAPIEN 3 with rigid frame (Fig. 7.6C). Identical material property and leaflet thickness
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(0.32 mm) were considered for the two models. The in-plane stress distribution of the
optimized geometry was considerably different from that of the 26-mm Edwards SAPIEN
3 (Fig. 7.6C). A peak leaflet stress of 0.86 MPa was found in the best design of TAV 26
mm close the fixed boundary edge. However, the peak in-plane maximum principal stress
for the SAPIEN 3 was 3.42 MPa close to the commissures. In other words, there was an
74.8% reduction in the peak in-plane maximum principal stress in the optimized TAV
geometry.
7.4 Discussion
7.4.1 Summary
In the present chapter, we presented an automated optimization framework to reduce
TAV leaflet stress under dynamic physiological loading condition. Commercially available
software packages such as MATLAB, SolidWorks, and ABAQUS/Explicit were linked
together using Isight to develop the optimization framework. In addition, particle swarm
optimization method was used to examine and explore the design space to obtain optimized
leaflet geometry for 23-mm and 26-mm TAVs. The optimized leaflet designs were
compared with two commercially available bioprostheses, i.e., Carpentier-Edwards
PERIMOUNT Magna surgical bioprosthesis and Edwards SAPIEN 3 transcatheter heart
valve. A considerable reduction in the peak maximum in-plane principal stress was
observed in the optimized TAV geometries than the commercially available bioprostheses.
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Figure 7.6: Comparison of leaflet stress distribution between the commercially available
bioprostheses and the best leaflet design configuration. Contours of the maximum in-plane
principal stress of (A) 23-mm Carpentier-Edwards PERIMOUNT Magna versus the best
TAV leaflet design with nominal size of 23 mm (B) 25-mm Carpentier-Edwards
PERIMOUNT Magna versus the TAV leaflet design with nominal size of 26 mm (C) 26mm Edward SAPIEN 3 versus the best TAV leaflet design with nominal size of 26 mm.
7.4.2 Optimization Framework for TAV Leaflet Design
During the past couple of years, a few computational frameworks has been developed
to optimize the design of bioprosthetic aortic valves leaflets to minimize the peak stress
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within the leaflets and achieve a better hemodynamic performance. Recently, Li and Sun
(Li and Sun 2017) performed an optimization framework to assess the impact of TAV
leaflet geometry on the leaflet stress distribution and to minimize its peak stress in both
circular and elliptical configurations. In the study, all initial 3D TAV geometries were
generated from 2D leaflet designs and were virtually assembled automatically in ABAQUS
using a Python script. A semilunar shaped 2D leaflet design consists of one leaflet–stent
attachment edge and one free edge that were parameterized by two exponential functions.
The computational parametric study was carried out to minimize the peak maximum
principal stress on the leaflets under quasi static pressure loading. The authors found a
range of leaflet peak stress between 0.87 MPa and 2.77 MPa under the nominal circular
configuration. The peak stress on the optimal leaflet design was 5% lower than the nominal
design derived from (Li and Sun 2010). In addition, the analysis showed that increasing
the free edge width had the highest overall impact on decreasing the peak stress value of
the leaflets (Li and Sun 2017). In a separate parametric study, Xu and colleagues (Xu et al.
2017) developed a computational framework to design patient-specific bioprosthetic heart
valves to analyze the impact of the leaflets geometry on valve hemodynamics. Two
NURBS curves were defined to parameterize the leaflets design, one free-edge curve and
one belly-region curve. The suturing line length and shape were kept constant and fixed in
the study. By changing the location of two control points of the NURBS curves, the valve
design was parametrically and manually altered. The study showed the potential of
parametric studies to create more effective design of bioprosthetic heart valves and reduce
patent-prosthesis mismatch (Xu et al. 2017). In this study, we introduced an effective
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approach to use commercially available software and explore a vast range of leaflet shapes
with only 6 parameters: valve height, leaflet coaptation height, and two control points for
the fixed-edge and free-edge B-splines. The framework creates three-dimensional leaflet
geometries efficiently and eliminate any residual stress that will be created by transforming
2D planer mesh into its 3D configuration, observed in previous studies (Li and Sun 2017).
The framework has the potential to determine optimized leaflet design for a wide range of
TAV design parameters and control variables. In addition, it is important to determine the
optimized leaflet geometry under dynamic loading condition. Simplified loading
conditions, e.g. quasi-static loading in the optimization procedure, may not represent the
true loading condition that the leaflets will experience following heart valve replacement
in clinical practice.
7.4.3 The Impact of Leaflets Design on TAVs Long-term Durability
In the past few decades, several computational simulations have been performed to
assess stress and strain distributions of bioprosthetic heart valves (Abbasi and Azadani
2015, Jermihov, Jia, Sacks, Gorman, Gorman III, et al. 2011, Abbasi et al. 2016, Abbasi
and Azadani 2017, Martin and Sun 2015, Wu et al. 2018) Computational modeling can
provide qualitative and quantitative insights into the durability of bioprostheses. The
increased mechanical stress on TAV leaflets may lead to accelerated tissue degeneration
and diminished long-term valve durability. Besides leaflet geometry, there are additional
factors such as TAV crimping (Alavi, Groves, and Kheradvar 2014b) and incomplete
transcatheter aortic valve expansion (Abbasi and Azadani 2015) that might affect the longterm durability of TAVs. Nevertheless, the results presented by our group and others
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underline the opportunity to improve TAV leaflet design in the next generation of TAVs
to enhance long-term durability of the bioprostheses.
Some limitations were inherent in this study. A major limitation associated with this
study was that the effect of TAV leaflet geometry was not studied on the valve
hemodynamics. Further studies are motivated to determine optimized TAV leaflet
geometry under physiological loading condition using fluid-solid interaction simulations.
In addition, in the optimization procedure, an isotropic nonlinear hyperplastic material was
assumed for the mechanical properties of the leaflets. Further studies are motivated to use
anisotropic material model for the leaflets in the optimization procedure and discretize the
3D model with structured mesh. Nevertheless, the optimized leaflet designs were compared
with Carpentier-Edwards PERIMOUNT Magna surgical bioprosthesis and Edwards
SAPIEN 3 using anisotropic material models. A considerable reduction in the peak inplane maximum principal stress was observed in the optimized TAV geometry in
comparison to the commercially available bioprostheses.
7.4.4 Study limitations
In FE simulations, we assumed a fixed value for Rayleigh damping coefficient to
mimic viscous damping effects of surrounding fluid in TAVs. In addition, the viscous
damping coefficient depends on the transvalvular pressure waveform and valve geometry
in TAVs (Abbasi et al. 2016, Abbasi and Azadani 2017). Therefore, a slight change in
design parameters in the optimization framework might alter the opening and closing time
of simulated TAVs in FE simulations.

A future study implementing fluid-structure

interaction into the TAV models may improve optimization results. For the sake of
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simplicity in the optimization framework, isotropic nonlinear hyperplastic material was
assumed for mechanical properties of the TAV materials. Since the optimization
framework was a side-by-side comparison study, our best designs should still be valid
without considering the impact of leaflet tissue anisotropy. Furthermore, the best TAV
designs in our optimization process showed a significant stress reduction compared to
commercially available valves.
7.5 Conclusions
In summary, we developed an automatic computational framework using
commercially available software to optimize the TAV leaflet shape under physiological
loading conditions. Optimized leaflet designs for two different TAV sizes (23-mm and 26mm) were obtained using particle swarm optimization algorithm. Furthermore, the impact
of leaflet design parameters was evaluated on leaflet maximum stress. The results showed
that increasing the ratio of valve height to leaflet coaptation height decreases the maximum
Von Mises stress of the leaflets. Furthermore, increasing the curvature of the fixedboundary edge could potentially reduce the maximum stress of the TAV leaflets. In
addition, the optimized leaflet designs were compared with Carpentier-Edwards
PERIMOUNT Magna surgical bioprostheses and Edwards SAPIEN 3 transcatheter heart
valve. A considerable reduction in the peak in-plane maximum principal stress was
observed in the optimized TAV geometry in comparison to the commercially available
bioprosthetic heart valves. The framework has the potential to determine optimized leaflet
design for a wide range of TAV design parameters and control variables (e.g., different
frame designs and leaflet properties). In addition, the results presented in this study
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underline the opportunity to improve leaflet design in the next generation of TAVs which
could potentially increase long-term durability of transcatheter heart valves.
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CHAPTER 8: CONCLUSIONS AND FUTURE WORK
TAVR is an established therapy alternative to surgical valve replacement in high-risk
and intermediate-risk patients with severe aortic stenosis. TAVR could potentially be
applied to lower-risk younger patients if the indications can be safely expanded to the
patients and TAV long-term durability can match with that of surgical bioprostheses. In
contrary to SAV, there have been limited clinical data on the long-term durability of TAV
devices. In the absence of enough long-term valve durability data, accurate structural
simulations and computational modeling become an integral part of the evaluation. Thus,
the objectives of this dissertation were to employ in-vitro experiments and inverse finite
element (FE) analyses obtain the accurate material properties of soft tissue employed in
commercial available TAVs and then to implement them in computational simulations to
determine leaflet stress and strain distributions for proper of the TAVs long-term durability
assessment. Therefore, the main goal of this study was to develop an automated
computational framework to minimize the peak stress on the leaflets under and optimize
the TAV leaflet shape under physiological loading conditions. In addition, the impact of
incomplete TAV expansion and thickness reduction on leaflet stress and strain distribution
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was assessed in this dissertation. Based on the context of this dissertation, the main
conclusions of the previous chapters are summarized in this chapter. Then we will propose
the future works related to the studies of this dissertation.
8.1 Conclusions
8.1.1 Incomplete TAV Expansion
The current guidelines for TAVR are to upsize the TAV relative to the native annulus
to secure the device and minimize paravalvular leakage. We have developed computational
models to assess the impact of incomplete TAV stent expansion on leaflet stress and strain
distributions. It was found that TAV leaflet stress and strain distributions were dependent
on the diameter of the inflated TAV. We found that 2-3mm incomplete TAV stent
expansion induced localized high stress regions within the TAV commissures, while 45mm incomplete stent expansion induced localized high stress regions within the belly of
the TAV leaflets during the diastolic phase of the cardiac cycle. In TAVR, valve oversizing
is essential to secure the valve and prevent paravalvular aortic regurgitation. However, if
oversizing leads to incomplete expansion of the stent, it will induce localized high stress
regions within the TAV leaflets which overtime may lead to premature tissue degeneration.
8.1.2 Material Characterization of Heart Valve Tissue
Constitutive models in computational simulations are needed to accurately predict and
simulate mechanical response of biomedical materials under a verity of multi-axial loading
conditions that may exist under physiological conditions. We developed an approach to
obtain material parameters of a pericardial surgical bioprosthesis based on generalized
nonlinear Fung-type constitutive model under dynamic loading conditions. Using the
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inverse parameter estimation process, 3D generalized anisotropic and orthotropic Fung
model parameters were estimated for the bioprosthetic leaflets. Furthermore, the Rayleigh
damping coefficient that was introduced to FE simulations to simulate viscous damping
effects of surrounding fluid was assessed. The generalized anisotropic model accurately
simulated the leaflet deformation and coaptation during valve opening and closing. During
systole, high stress regions were primarily observed at the boundary edge; however, during
diastole, high stress regions were primarily observed in the commissures. The maximum
leaflet stress at the peak of systole was significantly more than the maximum principal
stress during diastole. Commercial FE software packages are widely available and can be
utilized effectively for quantitative description of surgical and transcatheter heart valves to
better understand mechanism of tissue degeneration and improve long-term valve
durability.
8.1.3 Effect of Reduced Tissue Thickness in TAVs
Although low-profile systems reduce the risk of vascular injuries and improve catheter
maneuver for precise placement of TAV devices, the cross-sectional area reduction causes
more constraints in the design of TAV devices. To use smaller cross-sectional areas of
delivery catheters, the valve must be crimped into a small diameter which is less than the
delivery catheter size. We developed FE simulations to assess the impact of thickness
reduction on leaflet stress and strain distributions. It was found that TAV leaflet stress and
strain distributions were dependent on the tissue thickness of the TAVs. By reducing TAV
leaflet thickness to minimize the cross-¬sectional area of crimped TAVs, significantly
higher leaflet stress distribution is expected. Increased mechanical stress on TAV leaflets
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due to thickness reduction may lead to diminished long-term valve durability. As a result,
by using thinner leaflets, TAV durability may not match with that of surgical bioprostheses.
8.1.4 Strain Mapping of Bioprosthetic Heart Valves using DIC
To assess longevity of the currently available TAVs and develop the next generation
of heart valve prostheses, in-depth comparison and assessment of strain and stress of the
leaflets is essential. We developed an in-vitro DIC-based experiment to map displacement
and measure strain values on three different bioprosthetic heart valves, i.e., CarpentierEdwards PERIMOUNT Magna surgical bioprosthesis, Medtronic CoreValve, and Edwards
SAPIEN 3. High displacement regions were found at the leaflet belly region of the three
valves. In addition, the frame of the surgical bioprosthesis was found to be noticeably
flexible, in contrary to CoreValve and SAPIEN 3, in which the stent was rigid. We found
that high strain regions at the leaflet commissures in PREIMOUNT Magna and SAPIN 3.
However, the maximum strain value on CoreValve leaflets were found below the
commissure region close to the fixed boundary edge. The results of optical measurements
in the DIC system can be utilized to characterize the anisotropic materiel behavior of the
leaflets and validate computational simulations.
8.1.5 Material Characterization Framework for Commercial bioprostheses
Computational simulations can play a pivotal role in design and development of
prosthetic heart valves by reducing the need to perform expensive pre-clinical tests. To
have a reliable computational model, considering accurate mechanical properties for the
bioprosthetic materials is a crucial step. We developed a two-step optimization procedure
to determine 3D anisotropic mechanical properties of pericardial valves under
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physiological loading conditions. Three different bioprosthetic heart valves with
comparable size were investigated. The optimized material parameters for each valve were
implemented in FE simulations to assess the leaflet deformation and stress distribution.
During systole, high stress regions were primarily observed at the boundary edge for the
bioprostheses. However, during diastole, high stress regions were primarily observed in
the commissures for CE PERIMOUNT Magna and Edwards SAPIEN 3. In contrary to the
two other bioprostheses, the maximum stress values for the CoreValve were seen in the
lower leaflet belly region. In addition, the CoreValve had the lowest peak stress value at
the identical pressure value during diastole compared to the CE PERIMOUNT Magna and
Edwards SAPIEN 3.
8.1.6 TAV Leaflet Design
It is well-known that leaflet shape has a key role in hemodynamic performance and
durability of bioprosthetic valves. Excessive mechanical stress on transcatheter aortic valve
(TAV) leaflets may lead to accelerated tissue degeneration and diminished long-term valve
durability. We developed an automatic computational framework to optimize the TAV
leaflet shape under physiological loading conditions. The curves of the leaflet geometry,
fixed edge, free edge and symmetry curves, were parameterized using NURBS. The best
designs for two different diameters (23 and 26 mm) of TAVs were obtained using particle
swarm optimization (PSO) algorithm in Isight software. It was observed that high stress
regions were primarily observed at the boundary edge for the TAV designs at the peak of
systole. However, during diastole, high stress regions typically occurred near the
commissures. Among various perturbations of the leaflet design, increasing the ratio of
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commissure height to coaptation point height generally decreases the maximum stress.
Within the chosen design parameters, we have achieved new designs for TAVs leaflet
geometry in which the peak stress was 8.2% and 30.3% less than the corresponding surgical
valves for 23 and 26 mm diameters, respectively. In addition, the leaflet peak stress of best
TAV design obtained from the optimization framework showed the leaflet peak stress was
74.8% lower than the Edwards SAPIEN 3 TAV. The developed optimization framework
may provide a more reliable TAV design with longer valve durability in comparison to the
currently available TAVs.
8.2 Future Works
There are a few limitations in incomplete TAV expansion study which should be
addressed in future works. In this study, we only used the leaflet geometry which was like
the SAPIEN XT. Therefore, precise leaflet geometry of SAPIEN 3 valve or CoreValve
which are widely used in clinics can be considered in future works to assess leaflet stress
and strain distributions under incomplete TAV expansion. In addition, the effects of
crimping on the mechanical properties of tissue can be assumed in future FE models.
Additionally, we used a fixed value for Rayleigh damping coefficient to mimic viscous
damping effects of surrounding fluid in bioprostheses. However, the viscous damping
coefficient depends on fluid dynamics in bioprostheses. Therefore, a more accurate
simulation may involve FSI simulation in future works. Furthermore, to characterize
material parameters of soft tissue employed in bioprosthetic heart valves, FSI simulations
are also motivated under physiological loading condition in further studies. In this way, the
accuracy of material characterization can be increased, and the leaflets motion can be
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captured perfectly. In addition, we believe that the inverse FE simulations can be used to
obtain the in-vivo material model responses for human heart valves.(Lee et al. 2014, Lee
et al. 2016, Aggarwal and Sacks 2016)
In this dissertation, the in-vitro DIC-based experiment was conducted to map
displacement and measure strain values on commercially available bioprosthetic heart
valves under quasi-static loading. To obtain displacement and measure strain values within
bioprosthetic leaflets under dynamic loading conditions, pulse duplicator in-vitro system
and DIC system can be used simultaneously in future works. Accordingly, the
displacement and strain distribution of bioprosthesis leaflets can be obtained during one
cardiac cycle under physiological conditions.
We used the optimization technique to minimize the stress distribution within the
leaflet geometry in TAVs. However, implementing FSI simulation into the TAV models
may improve optimization results in future studies. Besides minimizing leaflet peak stress,
hemodynamic performance improvement and reduction of the incidence thrombosis can
be considered in future optimization frameworks for TAVs design. Moreover, the new
TAV design presented in this dissertation can be fabricated as a valve prototype and its
hydrodynamic performance can be assessed by in-vitro valve testing in the pulse duplicator
system. Accordingly, the optimized valve prototype can be hemodynamically comparable
with commercially available TAVs. Therefore, subsequent in-vitro studies should be
conducted to verify the best TAV design for different sizes in this study.
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APPENDIX
In the present study, non-uniform rational B-splines (NURBS) curves were used to
create transcatheter aortic valve (TAV) leaflet geometry. A NURBS curve is defined
(Hughes, Cottrell, and Bazilevs 2005)
∑p&- ¨&,t ×Ø& 3&
º× 
∑p&- ¨&,t (×)Ø&

(A.1)

where " is the order of a NURBS curve, ¨&,t are the B-spline basis functions, 3& are

control points, Ù is the number of control points and Ø& > 0 is a weighting factor. B-spline
basis functions given by (Hughes et al., 2005)
¨&, (×) = Û
¨&, (×) = 

1
0

9å

åæç 9å

Üf ×& ≤ × ≤ ×&Ý ÞÙß ×& < ×&Ý
á×ℎãØÜä
¨&,9 (×) + 
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(A.2)

where ×& are the knots forming a knot vector. The knot vector è is a set of é + 1
non-decreasing numbers.
è = × , × , … , × 

(A.3)
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Also, the degree of the basis functions " can be defined as
" =é−Ù−1

(A.4)

In this study, TAV leaflets with uniform thickness (t) were considered to be attached
to a frame with a uniform thickness of 0.5 mm and an external diameter of D. The 3D
leaflet geometry consists of two NURBS curves (i) the symmetric curve and (ii) the fixedboundary edge. The leaflet free-edge, that connects the commissure to the point of leaflet
coaptation, was subsequently reconstructed based on the symmetric curve and the fixedboundary edge. The symmetric curve was generated using a second order NURBS curve
(B-spline 1) in the plane of symmetry. The three controlling points of the Bspline, gq (!q , ëq ) , gq (!q , ëq ) and gqd (!qd , ëqd ), are shown in Fig. A.2. !q and ëq
were considered as the two design parameters for B-spline 1 in the plane of symmetry, bq

and ¿q , respectively. In addition, ëqd was taken as a parameter of ℎ (leaflet coaptation
height) to change coaptation height of the leaflets. As a result, the shape of the belly region
was controlled by three parameters, i.e., bq , ¿q and ℎ.
B-spline 2 controls the shape of the fixed-boundary edge. To create a fixed-boundary
edge for the leaflet, B-spline 2 was projected on the cylinder (the TAV frame) in the
MATLAB code. The three controlling points of B-spline 2, gh (!h , ëh ) , gh (!h , ëh )

and, ghd (!hd , ëhd ) are shown in Fig. A.2. !h and ëh were considered as the two design

parameters for B-spline 2, bh and ¿h , respectively. In addition, ëhd was taken as a parameter

of ì (valve height) to change the TAV height. As a result, the shape of the fixed-boundary

edge was controlled by three parameters, i.e., bh , ¿h and ì.
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As shown in Fig. A.1, the leaflet free-edge that connects the commissure to the point
of leaflet coaptation was reconstructed based on projection of two B-splines with degree
of 5 defined in Plane 3, the top plane of the TAV, and Plane 4, passing through TAV
centerline and perpendicular to the plane of symmetry (Plane 1). Five control points, i.e.,
gs !s , ës , gs (!s , ës ), gsd (!sd , ësd ), gs, (!s, , ës, ), gsË (!sË , ësË ), ÞÙß gsÌ (!sÌ , ësÌ ),
determine the shape of B-spline in Plane 3. In addition, another Five control points, i.e.,
g# (!# , ë# ), g# (!# , ë# ), g#d (!#d , ë#d ), g#, (!#, , ë#, ), g#Ë (!#Ë , ë#Ë ), ÞÙß g#Ì (!#Ì , ë#Ì )
, determine the shape of B-spline in Plane 4.
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Figure A.1: Design variables in parameterization of the TAV leaflet geometry.
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Figure A.2: Design variables and control points for generation of the NURBS curves. On
each plane, a local coordinate system was defined.
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